hg_177421.1

Basic information about the TSS

---

TSS ID: hg_177421.1 Species: human Chr: chr19		Start: 53874201 End: 53874230 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK027693 Distance: -460 GeneID: 91663 HGNC/MGI_ID: HGNC:7544 UniProt_ID:

Gene_name: myeloid associated differentiation marker Gene_symbol: MYADM Gene_synonyms: Gene_source: HGNC:7544

TATA-Box annotation

---

Distance to TSS:	4825
Nearest PromoterID:	NM_001290189
Entrez ID:	91663
Nearest Unigene:	Hs.380906
Nearest Refseq:	NM_138373
Nearest Ensembl:	ENSG00000179820
Gene Name:	myeloid associated differentiation marker
Gene Alias:	SB135
Gene Description:	myeloid associated differentiation marker
Gene Type:	protein-coding
CpG%:	0.045
GC%:	0.636816
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MYADM p2@MYADM p3@MYADM p4@MYADM p5@MYADM p6@MYADM p7@MYADM p8@MYADM p9@MYADM p10@MYADM
Sample		p1@MYADM	p2@MYADM	p3@MYADM	p4@MYADM	p5@MYADM	p6@MYADM	p7@MYADM	p8@MYADM	p9@MYADM	p10@MYADM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	45.00	27.27	0.00	0.39	0.39	0.58	0.00	0.00	0.39	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.62	24.68	0.20	0.20	0.40	0.61	0.00	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	41.86	23.73	0.00	0.19	0.19	0.96	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.23	17.05	0.00	0.83	0.83	0.62	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	36.67	15.52	0.00	0.45	0.45	0.00	0.00	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.14	16.47	0.19	0.39	0.58	0.39	0.00	0.00	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	26.36	21.79	0.00	1.53	0.22	0.00	0.00	0.00	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.25	25.19	0.00	0.00	0.24	0.73	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.00	25.65	0.85	0.21	0.00	0.00	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	6.38	0.00	0.58	0.58	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.57	7.28	0.40	0.00	0.40	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	8.94	0.00	0.00	0.00	0.00	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	80.60	31.75	4.51	1.13	1.77	0.81	0.97	0.48	1.29	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	82.24	30.22	3.31	1.20	1.50	1.50	0.75	0.45	0.90	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	74.87	27.88	3.07	1.54	1.32	1.54	1.10	0.44	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	82.49	30.18	2.77	1.01	0.25	1.01	1.51	0.50	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	91.51	30.58	2.84	1.31	1.75	1.53	0.66	0.87	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	94.49	24.89	3.37	2.11	2.11	4.22	0.42	0.42	2.53	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	114.63	33.06	2.67	1.07	2.13	1.07	1.07	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	90.87	34.45	3.16	0.90	0.75	2.71	1.05	0.60	0.60	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	94.49	30.07	3.47	1.47	0.67	1.47	0.94	0.94	1.07	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	119.11	37.46	5.35	2.24	1.38	1.55	0.86	0.00	0.69	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	111.03	27.40	3.75	2.20	2.20	1.81	0.65	0.65	0.90	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	109.69	26.69	3.64	0.73	1.46	1.46	0.24	0.73	1.21	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	126.41	31.22	3.61	1.81	1.55	2.58	0.52	0.52	1.03	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	113.63	33.23	4.11	1.58	0.95	0.95	1.27	0.32	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	155.50	43.96	2.75	2.75	0.00	2.20	1.65	1.10	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	161.96	31.83	4.24	1.65	1.41	0.94	0.71	1.65	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	131.48	28.43	3.23	2.10	2.42	1.62	0.48	0.32	1.29	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	117.27	26.60	4.16	1.81	0.72	1.09	0.36	0.00	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	117.86	29.10	2.51	1.67	1.47	1.67	0.42	0.42	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	111.37	28.33	3.91	1.76	1.37	0.78	0.39	0.39	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	130.21	33.55	4.43	1.90	2.11	2.95	0.21	0.21	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	156.36	30.51	2.80	2.80	2.80	2.31	0.66	0.00	0.82	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	116.12	26.18	3.93	1.87	2.24	2.62	0.93	0.37	1.50	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	113.44	19.16	2.11	1.15	1.53	1.53	0.77	0.38	1.53	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	123.45	21.66	2.86	1.64	1.23	1.84	0.41	0.00	1.64	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	115.45	27.20	2.42	2.42	1.41	2.22	0.81	0.81	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	113.98	21.07	3.51	1.89	1.35	1.89	0.54	0.00	0.54	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	104.91	19.93	2.64	0.24	2.40	3.12	0.48	0.24	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	96.22	19.53	3.76	1.41	1.88	1.88	0.00	0.47	1.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	117.41	21.67	2.93	2.20	1.32	2.49	0.59	0.88	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	104.39	19.19	3.59	1.27	0.21	1.69	0.21	0.42	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	120.63	22.90	3.15	2.10	1.40	1.40	0.87	0.52	0.35	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	113.84	18.47	5.42	0.60	0.60	1.61	0.20	0.20	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	116.56	18.61	3.26	2.09	2.09	1.40	0.00	0.23	1.16	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	116.59	16.07	5.52	1.44	0.72	1.20	0.72	0.72	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	108.79	15.20	4.77	2.09	2.38	2.09	0.00	0.89	0.00	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	115.38	17.47	4.31	2.87	0.72	1.91	0.24	1.68	1.68	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	115.45	18.00	5.86	2.22	1.01	1.62	0.81	0.20	1.01	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	137.11	26.44	6.35	3.69	0.82	1.84	0.82	0.61	1.64	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	139.43	27.35	7.78	1.56	2.22	2.67	0.89	0.89	1.56	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	145.14	24.13	6.39	2.13	2.13	2.48	0.71	0.71	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	133.88	32.48	7.95	1.33	1.66	2.32	0.99	0.33	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.95	15.94	2.52	2.52	3.36	3.36	0.00	0.00	2.52	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	118.48	27.55	6.89	0.46	3.21	1.38	0.00	0.00	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	170.48	41.16	10.05	3.24	2.59	3.24	1.30	0.32	1.94	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	150.31	25.37	6.42	3.21	1.93	2.57	0.64	1.28	2.57	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	148.05	37.09	4.71	4.71	1.26	5.34	0.94	1.57	2.51	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	305.99	45.83	14.10	3.53	3.53	3.53	0.00	1.41	4.23	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	288.24	43.74	12.34	3.93	2.80	3.36	3.36	1.12	4.49	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	160.82	43.79	5.57	2.39	3.18	5.57	0.00	0.00	5.57	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	280.65	33.98	8.83	4.42	2.72	5.10	1.70	0.68	2.38	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	363.59	43.54	14.62	7.80	1.95	7.15	1.62	0.97	2.92	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	362.08	36.21	13.13	5.68	5.68	7.45	2.13	1.06	2.48	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	32.33	0.00	32.33	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	15.79	0.00	0.00	7.90	15.79	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	533.34	40.95	13.65	8.29	7.31	8.29	2.44	0.49	4.88	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	584.63	25.29	10.91	7.93	5.45	8.43	1.49	0.99	4.96	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	588.27	22.99	14.54	7.97	2.81	4.22	0.47	0.94	3.75	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	332.18	23.18	8.94	2.98	1.99	5.96	0.00	0.00	1.99	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	337.49	36.19	8.66	7.73	4.02	6.19	0.62	0.00	6.19	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	319.81	19.87	8.26	4.89	3.97	7.03	0.00	0.61	3.36	1.53
Adipocyte - breast, donor1	11376-118A8	663.79	25.66	11.25	5.07	2.06	5.54	0.63	0.32	3.48	6.97
Adipocyte - breast, donor2	11327-117E4	406.36	35.29	5.78	11.39	5.13	7.06	0.16	0.32	6.42	5.13
Adipocyte - omental, donor1	11473-119C6	724.05	33.59	8.91	8.02	1.53	6.11	0.51	0.13	3.18	7.25
Adipocyte - omental, donor2	11474-119C7	529.97	31.39	7.47	4.48	5.98	16.44	0.00	0.00	5.23	2.99
Adipocyte - omental, donor3	11475-119C8	275.64	35.84	8.37	6.36	3.68	5.36	0.67	0.00	4.02	1.34
Adipocyte - perirenal, donor1	11476-119C9	330.48	22.33	6.38	5.10	3.19	3.19	0.00	0.00	2.55	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	208.91	6.60	0.00	3.30	0.00	2.20	1.10	0.00	0.00	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	191.49	14.45	6.77	0.45	0.90	2.26	0.00	0.00	0.45	5.87
Adipocyte - subcutaneous, donor3	11408-118E4	31.11	6.43	1.74	0.52	0.17	0.17	0.00	0.00	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	155.48	36.77	7.24	0.78	0.78	0.78	0.00	0.20	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	89.31	63.32	4.63	1.03	0.51	0.51	0.26	0.26	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	113.46	19.79	4.46	1.12	0.56	0.84	0.28	0.00	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	79.94	21.16	7.05	0.00	1.18	1.18	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	42.15	12.55	1.69	0.40	0.08	0.48	0.00	0.00	0.08	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	46.80	22.92	1.61	0.97	0.00	0.97	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	73.58	16.53	3.20	0.53	0.53	1.07	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	35.61	11.13	1.11	0.00	0.00	1.11	0.00	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	34.52	8.73	0.00	0.42	0.83	0.83	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	39.43	10.05	2.01	0.25	0.00	0.25	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	72.98	7.20	2.95	1.31	0.00	0.98	0.33	0.00	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	29.84	9.74	0.61	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	941.67	83.54	9.72	2.65	3.54	3.54	0.44	0.44	1.77	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	649.39	79.25	8.96	5.02	5.38	3.23	0.36	0.00	3.94	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	382.17	27.55	8.39	1.20	1.20	4.79	0.00	0.00	1.20	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	241.43	13.67	3.42	0.90	1.44	0.54	0.18	0.36	0.54	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	132.21	6.69	0.00	1.67	1.67	3.35	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	221.68	9.04	4.31	1.23	1.44	0.82	0.00	0.00	0.82	1.03
Anulus Pulposus Cell, donor1	11248-116E6	127.70	15.45	10.53	0.92	0.57	0.46	0.46	0.69	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	100.66	22.04	7.84	0.49	0.00	0.73	0.73	0.24	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	332.48	35.94	6.74	3.59	4.04	1.35	0.90	0.45	1.35	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	385.08	42.55	8.25	1.30	5.21	4.34	1.30	1.30	5.64	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	269.67	29.96	10.70	2.14	4.28	2.14	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	322.54	40.35	5.68	1.79	2.09	2.99	0.90	0.60	2.39	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	317.43	35.41	2.53	6.32	5.06	3.79	1.26	2.53	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	295.05	25.74	11.88	4.62	1.32	1.98	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	302.14	27.62	6.17	2.60	2.92	3.25	0.97	0.00	2.27	2.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	357.77	36.89	6.31	2.43	3.40	4.37	0.00	0.97	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	329.01	33.85	6.53	2.97	2.38	2.97	1.19	0.00	4.16	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	294.53	27.87	7.16	4.52	3.77	3.39	0.00	0.75	2.26	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	322.20	30.48	10.16	4.35	2.90	0.73	0.73	0.00	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	218.16	35.11	5.02	6.27	5.02	0.00	0.00	0.00	2.51	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	299.49	15.32	7.25	0.66	0.66	0.66	1.32	0.33	0.49	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	307.08	32.76	12.28	1.36	4.09	0.00	1.36	0.00	4.09	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	264.19	20.36	4.67	0.60	0.60	1.21	0.75	0.60	0.90	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	360.58	33.75	4.82	4.29	4.82	1.61	2.14	0.00	2.14	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	282.46	29.29	7.37	1.89	2.08	1.32	0.57	1.13	2.08	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	358.16	32.07	6.68	2.67	2.67	2.41	0.80	0.27	2.14	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	278.98	39.99	4.88	0.98	0.98	3.90	0.98	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	288.60	25.71	7.80	2.32	2.32	0.66	0.83	1.00	0.83	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	282.17	24.01	6.00	2.40	6.00	1.20	0.00	0.00	0.00	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	368.18	35.40	7.08	3.54	3.54	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	316.47	31.73	9.61	2.74	3.26	1.03	1.54	0.51	1.89	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	360.77	41.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	314.07	44.17	10.19	5.83	5.34	4.37	0.97	0.49	2.43	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	330.50	37.95	8.35	2.28	1.52	2.28	1.14	0.76	0.76	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	304.05	32.71	7.27	3.63	6.06	0.00	0.00	0.00	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	299.27	30.21	3.42	3.42	3.42	0.57	0.57	0.57	1.14	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	321.52	31.00	8.98	1.50	3.85	2.78	1.07	0.64	1.50	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	279.77	32.52	5.68	3.87	2.06	1.29	0.26	0.26	1.03	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	320.00	38.01	6.10	1.88	2.35	0.94	0.47	0.94	2.82	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	331.52	29.26	10.61	4.18	3.54	2.25	0.32	1.61	1.93	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	286.09	17.84	4.28	0.71	2.85	0.71	1.43	0.00	1.43	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	306.51	31.00	5.26	0.58	3.51	4.09	0.58	0.00	2.92	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	355.87	33.12	5.42	2.71	3.91	1.20	1.51	0.90	3.31	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	331.45	36.83	4.75	4.75	3.56	2.38	0.00	0.00	3.56	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	327.00	43.74	5.09	3.56	2.54	4.07	0.00	1.02	4.07	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	350.20	35.15	7.39	3.57	3.31	1.53	1.27	1.27	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	245.25	26.05	5.72	1.27	2.54	1.91	0.00	0.64	1.27	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	316.75	36.25	8.20	3.88	3.88	1.73	2.16	1.73	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	308.85	28.15	6.77	0.85	1.91	2.54	0.21	1.27	1.27	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	286.79	26.39	7.83	1.74	2.61	2.32	0.58	0.00	2.32	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	337.27	24.56	5.67	5.67	2.83	5.67	0.00	0.94	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	311.42	27.97	5.09	1.53	2.03	2.03	1.70	0.51	2.03	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	382.20	23.16	4.63	2.32	0.00	4.63	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	397.16	40.14	14.79	4.23	8.45	6.34	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	311.76	29.59	6.22	3.22	4.07	1.50	0.64	0.21	1.29	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	374.23	27.07	4.21	3.01	3.01	2.41	0.00	0.60	3.61	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	282.84	26.24	3.64	1.46	2.19	3.64	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	296.32	28.05	5.52	1.38	2.07	2.76	0.69	0.46	1.61	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	283.08	38.25	12.75	0.00	2.55	2.55	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	265.42	17.29	5.34	1.78	0.51	0.51	0.76	0.25	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	290.87	29.11	6.40	1.03	2.68	3.10	1.03	0.83	2.68	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	261.94	26.93	3.98	2.14	0.92	1.22	0.92	0.00	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	281.07	40.15	3.82	1.43	4.78	2.39	2.87	0.48	0.96	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	267.20	27.50	7.76	2.00	2.00	2.00	0.22	0.44	1.33	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	260.91	38.14	3.05	3.05	3.05	0.00	1.53	1.53	0.00	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	223.77	23.26	6.09	2.22	1.11	1.66	0.55	0.55	1.11	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	275.65	30.98	6.36	1.59	3.44	3.18	0.26	0.79	1.59	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	243.15	27.26	3.63	0.73	1.82	0.73	0.73	0.00	1.09	1.09
Astrocyte - cerebellum, donor1	11500-119F6	234.58	65.83	12.77	1.60	0.98	0.86	4.42	3.68	0.61	1.35
Astrocyte - cerebellum, donor2	11580-120F5	224.90	54.60	9.58	1.37	1.54	2.05	4.28	2.23	1.54	0.86
Astrocyte - cerebellum, donor3	11661-122F5	238.48	30.83	7.13	1.47	1.26	1.05	3.57	3.36	1.05	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	75.99	14.29	6.62	1.05	0.00	0.35	0.70	0.00	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	102.89	20.87	3.56	1.78	0.49	0.16	0.81	0.97	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	135.74	19.99	3.88	1.19	1.34	0.60	0.75	0.75	0.30	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.23	0.46	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.13	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	1912.33	75.32	5.23	4.18	1.05	1.83	0.26	0.00	2.09	1.83
Basophils, donor2	12242-129H1	1648.11	61.70	6.13	2.53	3.97	2.53	0.36	0.36	1.44	0.72
Basophils, donor3	12243-129H2	1311.80	69.82	7.06	3.97	2.06	2.50	0.15	0.15	1.62	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	151.14	1.29	2.59	0.86	0.65	0.65	0.00	0.00	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	300.83	8.69	10.06	1.83	1.83	1.83	0.46	0.00	3.20	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	0.00	0.00	7.17	7.17	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	87.87	5.02	1.26	0.63	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	152.84	3.95	5.61	1.87	0.21	1.25	0.21	0.00	1.04	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	99.02	1.38	2.53	1.15	0.46	0.46	0.00	0.00	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	73.60	1.80	1.08	0.54	0.90	0.18	0.00	0.00	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.10	1.44	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.41	14.91	0.00	0.00	0.47	0.23	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	353.99	149.33	3.84	0.64	0.96	0.32	2.24	1.28	0.32	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	237.86	103.42	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	488.60	42.83	5.64	0.56	3.38	0.00	0.00	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	810.15	66.45	7.05	4.08	4.27	2.41	0.00	0.00	4.27	3.71
CD14+ Monocytes, donor3	11381-118B4	759.82	47.86	4.83	3.29	3.73	3.29	0.00	0.00	2.20	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.96	16.42	0.57	0.00	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	88.70	14.03	0.76	0.76	0.38	0.76	0.00	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	16.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	2101.89	105.38	5.93	32.81	14.45	21.39	0.43	0.29	25.30	15.47
CD14+ monocytes - mock treated, donor2	11873-125C1	1284.22	68.80	3.62	16.60	5.73	11.77	0.00	0.00	9.05	5.73
CD14+ monocytes - mock treated, donor3	11883-125D2	1994.87	96.89	5.45	23.22	6.87	14.92	0.24	0.00	11.84	12.32
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1792.66	78.68	3.52	22.93	8.37	13.56	0.33	0.00	18.25	7.20
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1135.51	53.27	3.04	13.80	2.21	5.52	0.00	0.00	9.11	4.97
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1657.90	80.08	4.71	15.37	9.92	8.93	0.00	0.00	12.40	3.97
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1114.30	70.49	4.31	11.75	8.62	10.38	0.00	0.00	8.81	4.11
CD14+ monocytes - treated with BCG, donor2	11870-125B7	920.51	59.82	2.14	12.46	3.56	3.74	0.18	0.18	7.66	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	990.87	59.85	1.96	3.70	0.87	3.92	0.00	0.00	4.57	3.05
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1588.55	64.15	3.98	19.67	9.83	21.07	0.23	0.23	9.83	4.92
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1354.92	77.09	3.17	12.14	5.81	11.62	0.00	0.53	6.34	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1367.84	67.67	2.22	9.98	8.87	8.87	0.00	0.00	4.44	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1720.87	90.14	5.35	30.20	15.02	17.85	0.15	0.00	17.40	10.26
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	996.34	56.47	3.79	14.77	4.79	12.37	0.00	0.00	9.98	5.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1100.33	49.14	2.71	7.29	3.33	7.50	0.00	0.00	3.54	3.33
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2347.79	109.36	5.03	36.15	17.62	30.43	0.23	0.23	21.51	10.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1836.32	73.52	3.39	11.99	4.98	12.89	0.23	0.00	4.07	3.62
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1705.25	78.13	4.80	21.82	10.48	21.82	0.44	0.00	9.17	9.60
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1173.87	72.63	2.69	11.03	4.57	6.72	0.00	0.00	9.41	4.84
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1011.87	78.33	4.36	20.76	4.71	9.60	0.17	0.00	9.60	6.80
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1305.81	85.43	6.73	15.57	4.21	7.57	0.00	0.00	9.68	7.57
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1786.04	72.38	4.59	19.47	13.59	14.51	0.18	0.18	13.78	6.43
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1326.98	61.65	1.06	15.85	3.87	5.28	0.00	0.00	10.92	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1607.49	71.51	3.95	21.50	5.70	10.53	0.00	0.00	16.67	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	902.21	66.09	1.39	12.73	8.20	6.80	0.17	0.00	10.64	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	820.66	60.21	2.60	8.92	4.83	5.58	0.00	0.00	4.83	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1125.60	79.75	1.94	6.25	3.88	4.53	0.00	0.00	4.74	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1515.92	68.79	4.09	20.88	8.60	14.33	0.00	0.41	13.51	5.32
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1634.88	68.84	3.25	6.95	2.32	3.71	0.23	0.00	5.33	3.25
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1394.27	58.00	2.78	4.87	1.62	5.57	0.23	0.00	4.64	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	257.63	40.11	1.96	1.31	0.87	1.31	0.00	0.00	0.87	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	291.98	38.35	2.08	0.92	0.92	0.46	0.00	0.00	2.08	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	193.65	29.46	1.30	1.52	0.22	1.52	0.22	0.00	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	822.83	67.43	4.83	4.05	1.56	2.18	0.16	0.00	1.40	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	672.73	50.82	3.49	2.10	1.22	2.62	0.17	0.00	1.57	2.45
CD14+CD16- Monocytes, donor3	11910-125G2	1328.00	132.44	9.81	5.13	1.78	2.45	0.00	0.00	4.24	3.79
CD14-CD16+ Monocytes, donor1	11790-124B8	192.40	33.17	1.79	0.77	0.51	0.00	0.00	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	160.06	36.01	1.54	0.88	0.88	0.66	0.00	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	181.70	38.74	1.89	0.63	0.63	0.21	0.00	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	85.36	6.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	112.54	10.85	3.39	0.68	1.36	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	90.10	7.25	1.04	0.00	0.00	1.04	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	93.81	12.26	5.33	0.53	0.00	0.00	0.00	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	8.04	2.14	0.54	0.54	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	88.44	7.72	7.72	2.11	0.00	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	11.77	7.06	0.00	0.00	0.78	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	106.78	9.23	3.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	364.92	19.73	11.51	2.47	4.93	0.82	0.00	0.00	1.64	3.29
CD19+ B Cells, donor2	11624-122B4	338.05	24.66	5.08	1.45	0.73	2.18	0.00	0.00	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	590.65	30.29	7.57	3.53	3.53	1.01	0.00	0.00	2.52	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	16.57	16.16	0.40	0.00	0.40	0.00	0.00	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	8.79	8.79	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	340.37	42.17	6.02	1.00	0.00	0.00	1.00	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	384.84	33.15	3.93	0.56	0.00	0.00	1.12	0.56	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	214.56	116.11	2.25	1.50	2.63	0.75	1.13	1.13	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	246.23	139.12	2.03	0.68	0.45	1.35	0.68	0.68	0.45	0.68
CD4+ T Cells, donor1	11225-116C1	773.74	15.71	13.21	0.71	1.79	1.79	0.00	0.36	0.71	1.43
CD4+ T Cells, donor2	11306-117C1	589.71	14.08	6.74	3.67	3.06	1.84	0.00	0.61	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	553.56	10.98	10.37	3.66	4.57	2.74	0.61	0.00	1.83	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.57	1.53	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	23.13	3.37	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.13	2.87	3.16	0.57	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	152.66	8.53	6.64	0.47	0.00	0.47	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.02	3.51	5.62	0.00	0.00	0.00	0.00	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	89.00	9.89	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	178.33	22.54	8.67	1.01	0.58	2.02	0.14	0.43	0.58	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	120.15	10.17	8.98	0.51	0.51	1.02	0.00	0.00	0.68	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	98.01	15.64	8.71	0.97	0.81	0.48	0.00	0.16	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	158.70	3.59	5.83	0.90	0.45	0.90	0.00	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	111.45	0.35	5.24	0.35	0.00	0.35	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	164.99	1.76	5.72	0.00	0.44	0.44	0.00	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	137.88	66.62	8.43	1.26	0.42	0.00	0.00	0.00	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	90.17	53.40	6.23	0.42	0.21	1.25	0.00	0.00	1.04	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	89.55	66.49	4.01	1.00	1.00	0.33	0.00	0.00	1.00	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	362.76	31.00	19.31	1.90	0.00	0.54	0.27	0.00	1.36	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	209.02	26.26	15.01	0.00	0.54	0.54	0.00	0.54	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	243.88	37.66	16.14	3.59	1.79	3.59	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	277.03	33.56	8.34	1.48	0.74	1.48	0.00	0.00	0.74	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	213.15	27.73	7.15	1.52	0.22	1.73	0.22	0.00	0.87	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	257.02	27.32	9.67	1.68	0.84	0.84	0.00	0.00	0.42	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	235.11	4.55	9.61	0.51	0.51	0.00	0.00	0.00	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	161.60	4.33	6.93	0.00	0.00	0.87	0.00	0.00	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	319.45	8.72	10.02	0.87	0.87	0.44	0.00	0.00	0.87	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	201.91	11.38	8.91	0.00	0.49	0.49	0.00	0.49	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	184.64	4.62	11.08	0.00	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	156.33	2.79	5.58	0.00	0.00	0.00	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	284.96	16.89	13.85	1.11	0.00	0.55	0.28	0.55	1.11	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	286.86	18.90	13.01	1.23	0.74	1.96	0.25	0.00	1.23	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	306.46	18.48	7.70	0.00	0.00	0.00	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	382.11	15.04	10.74	2.51	0.36	0.00	0.00	0.00	1.07	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	232.68	8.31	13.85	1.38	1.38	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	696.70	10.15	7.20	2.62	4.26	1.31	0.00	0.00	0.98	1.64
CD8+ T Cells, donor2	11307-117C2	682.91	12.76	4.51	4.88	3.38	3.38	0.38	0.75	1.88	1.88
CD8+ T Cells, donor3	11383-118B6	668.59	18.43	12.12	4.04	1.77	2.02	0.25	0.50	2.27	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	197.74	26.15	2.06	1.38	1.15	1.15	0.00	0.00	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	191.71	25.88	2.16	1.20	1.20	1.20	0.48	0.72	0.96	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	191.79	32.56	1.64	1.92	1.37	1.92	1.09	0.27	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	342.54	31.52	4.80	2.40	0.60	2.10	0.00	0.60	0.90	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	306.46	30.24	3.84	1.44	2.16	1.68	0.24	0.48	1.92	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	293.78	27.74	5.46	1.59	3.64	0.91	0.00	0.68	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	101.25	25.20	1.96	0.22	0.22	1.09	0.22	0.00	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	110.28	33.69	2.37	1.32	1.84	0.79	0.00	0.00	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	104.59	27.67	2.81	0.00	0.70	0.70	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	87.54	46.49	3.92	1.81	0.30	0.60	0.00	0.30	0.91	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	71.75	29.63	1.16	1.45	1.45	1.16	0.00	0.58	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	66.08	37.57	3.73	1.87	1.33	1.07	0.00	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	203.55	16.63	2.19	2.63	0.44	0.44	0.00	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	196.75	21.41	2.28	0.91	1.37	0.91	0.00	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	284.18	23.12	4.48	1.49	0.00	1.49	0.75	0.00	1.49	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	300.73	25.93	4.68	1.44	2.16	1.80	0.36	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	303.55	29.64	5.47	1.73	2.01	1.44	1.15	0.00	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	292.03	23.81	5.42	1.65	1.65	0.00	0.24	0.00	0.24	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	156.55	30.42	4.44	1.58	1.27	0.95	0.32	0.00	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	150.71	29.22	4.31	0.62	0.92	0.92	0.00	0.31	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	177.92	19.88	6.09	0.96	1.28	0.32	0.00	0.32	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	106.71	32.89	2.68	1.15	0.00	0.76	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	104.04	25.22	2.36	0.79	1.18	0.79	0.00	0.00	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	103.63	34.80	2.27	0.00	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	113.22	17.67	3.21	0.00	0.80	0.80	1.61	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	108.41	23.08	4.90	0.70	0.00	0.00	0.70	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	136.24	21.04	4.01	1.00	1.00	0.00	0.00	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	433.17	36.55	5.48	0.00	1.83	0.00	0.00	0.00	7.31	1.83
Cardiac Myocyte, donor2	11605-120I3	202.08	52.87	3.95	1.48	1.48	0.49	0.00	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	437.45	33.46	5.26	1.16	1.05	0.42	0.84	0.74	0.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	511.33	50.96	10.05	4.51	4.51	3.47	0.00	0.00	2.08	3.81
Chondrocyte - de diff, donor2	11338-117F6	357.15	11.02	13.86	2.13	1.78	2.49	0.36	2.49	0.36	3.55
Chondrocyte - de diff, donor3	11410-118E6	243.83	16.73	11.38	2.50	2.96	2.73	0.23	0.46	1.37	3.07
Chondrocyte - re diff, donor2	11339-117F7	286.48	13.43	20.59	1.79	0.00	2.69	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	217.16	8.49	11.32	2.02	2.02	0.81	0.40	0.40	2.43	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	186.60	70.35	6.08	1.84	1.61	0.92	2.98	3.10	0.46	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	188.97	52.80	7.48	2.14	1.07	1.28	1.50	1.07	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	203.10	64.69	6.02	2.65	1.95	1.59	2.12	1.59	1.33	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	374.32	76.94	21.55	2.02	1.19	1.93	2.84	4.03	1.56	1.10
Corneal Epithelial Cells, donor1	11526-119I5	144.48	2.20	5.05	0.22	0.44	0.44	0.00	0.22	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	40.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	54.19	2.05	1.79	0.26	0.00	0.26	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.90	5.61	0.33	0.33	0.17	0.17	0.00	0.00	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	18.29	3.47	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	41.14	8.64	0.54	0.22	0.65	0.43	0.00	0.00	0.11	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	241.88	49.20	9.91	1.02	0.68	1.02	0.68	2.73	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	134.49	16.97	5.88	0.00	0.00	0.00	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	159.22	35.81	10.16	0.00	0.48	0.00	0.97	2.42	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	225.81	6.84	6.67	0.50	0.50	0.33	1.33	0.00	0.67	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	231.78	14.67	4.69	0.00	0.59	1.17	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	313.34	12.16	7.92	0.85	0.85	0.28	1.41	0.85	0.57	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	248.89	12.58	9.44	0.00	0.39	0.79	0.39	0.39	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	387.15	11.63	6.40	1.16	1.45	3.20	0.29	0.58	2.04	3.49
Endothelial Cells - Artery, donor2	11341-117F9	265.16	18.82	6.82	2.12	3.29	3.29	0.24	0.24	3.53	1.18
Endothelial Cells - Artery, donor3	11413-118E9	198.10	14.55	4.91	2.10	0.88	1.58	0.53	0.35	1.05	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	215.00	5.76	9.97	0.66	0.66	0.22	0.22	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	275.67	12.78	16.43	1.22	0.91	0.00	0.61	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	293.46	11.84	16.07	1.97	0.85	1.13	1.69	0.28	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	264.15	7.43	12.78	1.19	2.67	1.49	1.19	0.59	1.19	2.67
Endothelial Cells - Microvascular, donor2	11342-117G1	268.66	14.06	6.77	2.60	1.04	1.04	0.52	0.00	2.60	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	273.79	6.66	6.66	3.12	1.56	1.99	0.71	0.43	1.56	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	268.88	17.21	8.80	0.80	1.60	0.80	0.00	0.00	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	312.38	26.73	12.58	2.10	1.57	1.57	0.52	1.05	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	152.95	22.49	5.96	0.62	0.75	0.75	0.50	0.37	0.50	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	104.50	19.99	7.82	0.00	0.22	0.43	1.30	1.09	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	182.46	19.30	8.43	0.37	0.37	0.85	0.61	0.12	0.12	0.37
Endothelial Cells - Vein, donor1	11267-116G7	194.51	15.93	2.28	1.14	0.00	0.00	1.14	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	299.66	8.38	6.29	1.40	0.00	0.70	1.40	0.70	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	205.99	9.73	7.07	0.79	1.10	1.73	0.94	0.16	0.79	0.63
Eosinophils, donor1	12244-129H3	152.47	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1303.71	569.34	11.55	13.20	1.65	6.60	1.65	0.00	1.65	3.30
Eosinophils, donor3	12246-129H5	1216.29	460.12	3.57	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	169.32	1.95	3.18	0.73	1.22	0.00	0.00	0.00	0.98	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	95.69	2.08	0.00	0.00	0.00	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	211.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	356.74	42.69	9.03	3.69	1.64	3.69	0.82	1.23	0.82	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	284.78	36.57	5.36	8.65	4.27	6.46	0.11	0.11	4.49	5.47
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.60	5.31	1.19	1.30	0.54	0.76	0.33	0.00	0.76	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	419.75	32.14	7.64	4.49	3.64	6.19	0.97	0.61	2.30	4.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	727.26	38.08	11.60	4.50	1.23	3.68	1.09	0.27	2.18	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	364.71	34.91	8.96	7.28	4.22	4.54	1.27	0.21	6.01	3.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	975.97	50.33	16.86	8.43	8.17	9.49	1.58	0.53	3.95	3.95
Fibroblast - Aortic Adventitial, donor3	11401-118D6	407.94	26.24	7.64	6.64	4.32	5.65	0.00	1.00	1.33	4.32
Fibroblast - Cardiac, donor1	11268-116G8	213.20	37.65	3.63	0.91	0.45	1.36	0.45	0.00	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	794.33	53.06	12.89	3.79	3.03	3.03	1.52	3.03	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	406.28	30.91	12.62	3.31	2.84	4.89	0.95	0.47	2.84	3.15
Fibroblast - Cardiac, donor4	11452-119A3	336.15	22.73	7.58	1.21	0.61	1.21	0.30	0.61	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	286.68	14.47	8.25	4.06	1.40	1.90	0.76	0.25	1.27	1.02
Fibroblast - Cardiac, donor6	11460-119B2	318.35	18.19	5.46	3.03	2.27	3.64	0.45	0.30	0.91	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	266.11	28.54	18.09	0.54	0.94	0.54	1.74	2.01	0.80	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	150.57	13.37	12.08	1.29	0.86	1.29	0.00	0.86	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	379.38	60.06	7.32	2.93	1.46	1.46	2.93	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	176.90	14.07	6.46	0.46	0.23	0.46	0.69	0.92	0.00	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	311.39	12.38	4.24	1.19	1.19	0.51	1.19	0.34	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	178.43	5.63	4.46	0.94	0.94	3.99	0.00	0.00	0.94	2.11
Fibroblast - Dermal, donor2	11346-117G5	289.61	3.77	7.55	0.47	1.42	0.00	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	307.05	7.37	7.49	1.93	3.14	3.14	0.12	0.00	0.97	1.93
Fibroblast - Dermal, donor4	11450-119A1	115.42	5.88	7.57	1.58	1.02	0.68	0.45	0.11	1.36	0.11
Fibroblast - Dermal, donor5	11454-119A5	145.84	11.17	5.76	1.05	0.52	1.05	0.17	0.17	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	172.66	13.64	7.47	1.79	0.97	0.81	0.32	0.16	1.30	0.32
Fibroblast - Gingival, donor1	11237-116D4	200.11	8.95	9.37	0.42	1.46	0.83	0.21	0.21	0.42	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	590.55	31.44	10.48	6.81	3.41	6.81	0.79	0.52	3.14	4.19
Fibroblast - Gingival, donor2	11318-117D4	164.86	13.97	7.51	0.92	1.32	1.05	0.40	0.26	0.66	0.40
Fibroblast - Gingival, donor3	11394-118C8	170.56	7.44	10.25	1.74	0.87	0.68	0.10	0.19	1.26	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	371.92	12.47	8.31	5.19	2.08	5.19	1.04	0.00	0.00	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	348.00	15.68	9.51	5.81	2.82	4.41	0.18	0.35	4.23	3.17
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	364.33	35.39	9.04	1.56	1.71	1.40	0.62	0.62	1.40	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	361.06	18.80	8.38	3.11	1.35	1.22	0.27	0.14	1.22	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1260.49	68.46	19.41	5.65	1.76	13.06	1.06	0.35	0.71	8.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	423.38	32.17	7.17	2.19	1.61	3.07	0.44	0.73	0.44	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	374.84	33.41	7.36	2.59	1.91	2.86	0.14	0.14	1.50	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	487.04	39.27	5.37	3.73	0.99	2.52	0.33	0.33	1.43	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	481.74	10.86	18.93	5.28	2.20	6.16	0.88	0.88	1.91	6.90
Fibroblast - Lung, donor1	11270-116H1	213.42	5.44	4.08	0.00	0.00	0.00	0.00	1.36	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	211.89	5.97	10.45	1.49	0.00	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	162.50	7.81	5.70	0.63	0.63	1.27	0.00	0.21	1.48	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	2699.82	154.11	34.99	5.00	0.83	0.00	1.67	0.83	5.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	791.62	32.17	15.38	5.59	2.80	4.20	1.40	0.00	2.80	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	593.06	33.59	10.92	5.88	3.64	3.08	0.00	0.28	2.80	3.08
Fibroblast - Mammary, donor1	11540-120B1	1321.02	46.69	32.07	1.62	1.62	1.62	0.81	0.81	2.44	2.03
Fibroblast - Mammary, donor2	11620-122A9	798.84	31.95	7.99	7.99	0.00	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	667.10	23.83	5.96	0.00	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	149.55	5.63	6.40	0.19	0.78	0.00	0.19	0.00	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	172.01	15.32	7.28	1.67	0.61	1.52	0.30	0.15	1.97	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	470.91	12.55	11.93	0.61	1.22	0.92	0.31	0.00	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	557.93	17.94	9.92	2.67	0.38	0.76	1.91	0.00	2.29	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	448.18	31.86	8.64	5.67	3.51	3.51	0.27	0.54	4.59	2.70
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	341.78	14.38	16.24	3.71	1.97	4.64	0.46	0.81	1.28	2.09
Fibroblast - Pulmonary Artery, donor1	11250-116E8	381.56	31.06	6.63	0.88	1.22	1.44	0.77	0.33	1.22	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1421.32	73.56	25.40	2.84	5.08	2.03	0.41	0.20	2.84	2.24
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	344.12	15.37	11.36	1.34	2.00	2.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	156.56	6.72	5.93	0.40	0.79	0.00	0.00	0.00	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1085.71	72.83	19.84	4.96	4.17	4.37	0.79	1.19	3.37	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	479.92	13.68	16.34	1.95	1.42	2.49	1.24	0.18	0.53	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	659.64	23.45	10.84	2.37	4.53	1.97	0.39	0.39	1.18	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1086.99	44.83	14.44	5.42	2.11	5.42	1.20	0.30	3.31	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	504.57	21.05	13.71	3.02	2.16	2.91	0.32	0.32	2.70	2.27
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	649.39	24.04	15.44	4.05	2.78	3.54	0.76	0.51	2.02	2.53
Fibroblast - skin normal, donor1	11553-120C5	481.73	16.74	14.44	1.64	2.30	1.48	0.33	0.49	1.64	2.13
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1944.72	89.23	28.27	7.42	4.01	6.22	2.61	1.40	5.01	3.21
Fibroblast - skin normal, donor2	11561-120D4	727.45	27.93	14.57	4.82	3.82	4.42	0.90	0.60	3.42	2.91
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	848.38	44.13	18.13	4.23	2.42	4.53	1.81	2.42	1.21	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	568.24	14.58	13.09	3.23	1.74	2.40	0.83	0.50	1.16	2.32
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	368.40	23.76	15.39	3.25	2.22	3.42	0.85	0.34	2.39	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1364.96	54.85	22.00	5.91	4.60	5.25	1.31	1.31	4.27	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	475.62	29.51	9.91	3.41	2.77	2.66	0.53	0.53	1.81	2.45
Fibroblast - skin walker warburg, donor1	11554-120C6	548.89	33.57	10.96	2.70	2.36	1.69	0.84	0.51	2.19	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	182.69	18.98	3.45	3.45	4.08	1.88	0.16	0.00	2.82	2.20
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	1.74	0.87	0.00	0.00	0.87	0.00	0.87	0.00	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	146.66	2.43	1.56	0.52	0.00	1.04	0.00	0.17	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	196.22	4.16	2.86	0.52	0.52	1.82	0.00	0.00	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	200.83	4.34	2.30	1.53	0.00	2.04	0.00	0.00	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	170.72	44.40	4.59	6.12	3.06	2.30	2.30	8.42	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	140.38	47.22	5.10	0.64	1.91	2.55	6.38	6.38	1.91	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	118.38	24.53	7.70	1.14	0.86	1.71	5.71	3.42	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	92.93	33.37	11.31	4.14	3.03	9.93	9.93	18.75	1.38	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	57.31	17.12	5.02	2.05	1.37	2.28	9.13	14.16	0.46	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	106.40	28.93	7.73	1.98	0.59	2.77	8.12	6.14	0.99	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	73.22	35.16	7.14	1.06	2.91	8.72	7.67	13.22	0.79	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.08	17.61	8.48	1.96	0.98	2.28	7.50	8.48	1.96	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	118.07	29.63	7.08	1.33	0.88	1.33	4.86	5.75	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	133.69	31.09	8.90	1.41	1.55	1.55	9.61	11.73	1.84	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	108.98	26.97	8.00	0.86	1.11	1.72	7.76	9.36	0.62	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	114.70	34.92	4.84	2.15	2.15	1.07	6.45	6.98	0.81	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	275.42	19.58	16.85	2.35	2.48	2.23	9.29	11.27	2.48	2.23
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	303.43	25.06	19.93	2.35	2.91	1.80	10.38	13.29	1.66	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	296.82	31.72	13.01	2.24	1.83	1.42	9.35	9.15	2.24	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	179.12	18.71	8.21	0.46	1.60	2.28	5.02	5.02	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	169.66	12.33	10.84	1.87	1.74	1.49	4.86	4.86	0.12	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	284.81	14.64	13.77	0.87	1.09	0.87	9.62	9.40	0.66	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	145.38	24.82	7.68	2.36	2.36	2.95	6.80	2.95	0.89	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	143.06	19.23	11.13	0.79	0.79	0.79	8.11	9.38	0.95	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	187.00	20.33	6.48	1.56	0.45	1.12	6.26	4.92	1.12	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	138.93	19.36	7.86	2.02	1.41	1.01	7.26	5.65	0.40	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	108.06	17.98	8.82	0.85	0.68	1.19	7.12	7.63	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	337.84	37.51	11.08	1.68	1.42	1.60	6.21	7.18	1.33	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	340.99	41.62	23.52	3.54	1.04	0.73	15.50	12.38	1.98	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	303.81	38.25	19.81	3.07	0.51	2.73	13.83	7.51	1.71	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	118.07	16.38	13.94	1.22	0.55	1.00	7.75	7.75	0.89	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	189.94	27.70	10.73	0.92	1.33	1.33	5.24	5.57	0.75	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	202.75	26.54	10.41	0.00	0.41	1.23	7.76	5.31	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	142.97	21.66	9.70	1.24	0.83	1.24	8.25	6.60	0.83	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	124.52	16.37	13.95	1.50	1.38	1.27	10.15	10.49	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	124.91	13.67	11.01	0.67	1.67	1.33	5.67	6.17	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	147.91	15.43	13.01	1.76	1.10	0.88	8.38	3.97	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	130.49	15.87	12.55	0.86	1.23	1.72	6.40	6.64	0.61	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	115.57	20.75	9.89	0.49	0.97	0.97	8.59	6.65	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	155.55	18.92	13.15	0.64	1.28	0.64	11.55	5.45	0.96	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	101.20	8.34	12.89	0.57	0.57	0.85	8.72	7.96	0.57	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	111.36	9.49	9.81	1.27	0.79	0.95	5.22	3.80	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	152.65	13.68	20.68	1.52	1.52	1.22	6.08	5.17	0.30	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	109.56	9.51	13.90	1.36	0.84	0.73	6.90	7.21	0.52	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	110.22	7.68	9.66	0.44	1.32	1.54	5.93	3.95	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	131.02	9.26	13.75	0.56	1.12	0.28	4.49	7.01	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	121.75	11.30	12.59	2.04	0.74	0.65	2.78	2.22	1.02	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	113.91	10.43	10.16	0.80	1.60	0.80	1.34	2.41	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	176.26	13.77	14.69	0.77	1.53	0.61	3.98	2.14	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	129.80	8.16	15.41	0.65	0.91	1.04	2.07	2.20	0.26	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	108.70	9.22	8.13	0.54	0.27	1.63	1.08	0.81	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	218.46	14.93	16.41	2.03	1.66	1.11	4.98	1.84	1.29	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	211.42	9.65	15.13	2.41	0.88	2.85	3.95	1.75	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	344.14	30.74	41.65	1.98	5.95	1.98	8.93	14.88	0.99	4.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	296.54	11.21	10.95	1.06	2.51	1.71	2.51	2.77	0.66	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	294.16	11.70	13.32	2.02	2.22	1.21	3.03	2.42	1.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	817.89	50.32	78.28	11.44	1.02	1.52	19.57	11.69	2.03	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	134.56	52.95	8.96	0.60	0.80	1.19	4.38	8.76	0.40	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.98	28.81	6.78	1.54	1.08	1.08	3.85	7.70	0.62	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	98.40	39.89	7.57	1.02	0.20	0.61	2.66	9.21	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	68.84	26.91	2.50	0.31	0.31	0.63	3.13	6.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	57.08	26.84	5.09	0.57	0.00	0.57	3.67	5.37	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	56.73	38.28	6.46	0.92	0.46	0.00	5.53	13.37	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	113.84	32.17	0.00	4.95	0.00	0.00	7.42	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	113.72	27.46	7.35	3.48	1.93	0.39	3.48	5.03	0.77	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	144.40	28.88	4.81	1.60	0.00	0.00	6.42	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	102.59	29.56	8.69	1.74	0.00	0.00	5.22	12.17	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	120.75	21.81	5.86	1.30	1.63	3.25	6.18	6.51	1.95	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	137.13	36.24	5.77	1.65	1.65	1.65	4.94	8.24	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	156.62	49.98	3.33	3.33	3.33	3.33	6.66	6.66	6.66	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	144.30	31.88	3.36	1.68	1.40	1.96	4.19	8.39	1.68	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	147.41	30.07	5.88	2.61	2.61	0.65	5.56	5.23	1.96	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	148.47	42.78	7.55	1.68	0.84	2.52	11.74	10.07	1.68	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	189.57	42.94	7.00	2.86	3.18	1.27	7.00	6.04	2.23	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	194.29	41.44	9.17	1.36	2.04	2.04	4.42	8.49	0.68	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	121.11	45.94	4.18	4.18	0.00	2.09	4.18	4.18	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	188.42	47.53	3.44	3.44	2.29	1.72	9.16	12.60	2.29	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	183.51	36.41	8.88	2.07	2.66	2.07	7.99	9.18	2.07	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	144.00	20.33	1.69	1.69	0.00	0.00	8.47	8.47	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	220.77	40.18	6.63	2.49	2.49	4.14	13.25	7.04	2.49	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	131.63	44.41	8.51	2.76	2.07	2.30	9.67	8.51	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	163.32	68.49	10.54	0.00	0.00	5.27	0.00	15.81	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	142.23	31.14	5.38	1.92	2.69	1.54	11.92	8.84	0.77	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	198.19	34.23	10.11	1.96	2.61	2.28	11.73	10.76	0.65	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	151.83	27.42	4.01	0.67	0.67	2.68	12.71	8.69	2.01	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	189.17	44.31	9.25	3.47	3.08	1.54	14.25	12.33	0.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	638.46	79.77	8.90	6.85	5.82	6.16	13.35	4.45	2.40	6.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	213.69	49.70	12.42	4.97	0.00	4.97	19.88	12.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	173.17	45.77	6.13	3.77	1.89	5.19	11.80	13.21	1.89	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	172.00	37.42	8.45	3.02	1.81	4.22	11.47	13.28	1.81	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	176.51	33.57	8.14	4.07	1.02	3.56	12.21	11.19	2.03	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	145.18	40.68	9.17	3.19	2.39	2.39	15.16	13.96	1.99	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	163.30	40.95	9.37	1.48	1.48	0.49	10.85	16.28	1.97	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	173.52	38.95	5.90	1.18	2.36	1.18	5.90	3.54	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	138.86	40.26	6.42	1.75	3.50	1.17	14.59	12.25	2.33	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	195.30	49.15	6.58	0.44	0.88	2.19	8.34	5.27	1.76	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	245.83	72.90	5.93	9.32	0.85	3.39	8.48	8.48	6.78	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	174.90	43.57	4.78	2.39	2.98	0.00	9.55	4.78	2.39	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	108.21	38.33	8.25	1.46	1.46	0.97	15.04	5.82	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	296.74	25.11	4.57	2.28	0.00	2.28	0.00	0.00	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	318.52	18.30	12.06	3.74	2.08	2.08	1.66	1.25	2.49	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	380.07	14.62	9.00	1.12	1.12	2.25	0.00	0.00	1.12	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	235.65	11.10	11.42	0.95	3.17	0.95	0.32	0.00	1.59	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	95.25	9.19	6.68	2.09	1.25	0.00	0.00	0.42	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	47.00	27.85	2.32	0.58	0.81	0.35	0.12	0.23	0.35	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	52.83	23.63	1.18	0.17	1.18	0.17	0.00	0.00	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	38.45	22.75	1.14	0.46	0.91	0.23	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	69.30	26.34	1.20	0.77	1.20	0.87	0.44	0.22	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	72.21	24.93	1.07	1.29	1.07	1.29	0.21	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.33	17.65	1.51	0.22	1.08	0.22	0.00	0.00	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	59.28	24.53	1.37	0.62	1.37	0.12	0.12	0.12	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	63.99	20.76	1.03	1.20	1.20	0.17	0.51	0.00	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	55.10	21.79	1.28	0.32	1.28	0.32	0.00	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	271.42	30.22	15.11	1.68	1.12	2.24	0.00	0.00	2.80	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	590.33	45.88	12.12	5.63	3.03	3.03	1.30	0.43	2.16	4.33
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	335.76	29.08	0.00	0.00	0.00	0.00	2.64	0.00	2.64	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	668.76	62.08	10.23	2.82	3.88	1.76	1.41	2.12	1.41	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	709.08	53.04	7.27	4.36	4.36	3.63	2.18	1.45	4.36	3.63
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	241.45	37.24	4.90	2.10	1.92	1.22	0.00	0.35	1.05	0.17
Hepatocyte, donor1	11523-119I2	7.26	25.42	0.00	0.00	0.00	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	22.62	57.10	0.00	1.08	1.08	2.15	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	55.83	28.22	1.23	0.61	2.45	2.45	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	4.57	25.45	0.65	0.65	0.00	0.65	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	146.47	36.01	1.05	1.75	1.92	1.57	0.00	0.00	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	305.01	44.32	6.86	2.06	1.51	0.96	0.14	0.82	0.14	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	124.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	120.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	216.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	114.90	0.00	1.38	0.00	1.38	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	132.64	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	118.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	99.95	0.00	0.00	0.00	0.00	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	132.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	120.20	0.00	0.00	0.00	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	118.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	87.13	0.00	0.00	7.26	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	124.41	0.00	1.32	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	111.97	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	104.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.12	86.29	0.00	0.63	0.00	0.63	0.00	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	91.25	0.00	0.00	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	87.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	118.22	0.00	1.29	0.65	0.65	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	117.52	1.61	1.61	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	119.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	12.22	121.42	0.00	1.63	0.81	0.00	0.00	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.25	141.90	0.00	0.84	0.00	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	43.12	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	123.77	0.00	2.41	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	90.48	0.00	0.92	0.92	0.00	0.00	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.91	94.88	0.00	0.00	0.47	0.00	0.00	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	99.77	0.00	2.72	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	117.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	92.55	0.00	0.00	0.00	0.00	0.00	0.00	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	109.26	0.00	2.54	1.27	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	22.96	135.19	0.00	1.28	0.00	0.00	0.00	0.00	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	83.84	0.00	1.82	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	14.28	134.96	0.00	0.71	1.43	0.71	0.00	0.00	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	132.73	0.00	3.32	0.00	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	104.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.26	94.45	0.00	0.31	0.93	0.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	198.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	116.30	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	139.08	0.00	0.00	0.00	0.70	0.00	0.00	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	172.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	132.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	104.63	0.00	0.87	0.00	0.87	0.00	0.00	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	130.49	0.00	0.00	2.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	125.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	87.48	1.07	0.00	0.00	0.00	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	130.23	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	108.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	92.04	0.00	0.00	0.92	0.92	0.00	0.00	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	130.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	31.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	82.47	0.00	1.06	1.06	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	315.87	4.16	2.94	1.63	0.73	1.31	0.00	0.08	1.06	1.88
Keratinocyte - epidermal, donor2	11349-117G8	63.25	0.00	2.34	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	113.11	2.93	4.07	0.95	0.95	0.76	0.09	0.00	0.57	0.38
Keratinocyte - oral, donor1	11251-116E9	136.33	2.27	5.90	1.02	0.91	0.34	0.00	0.11	0.34	0.34
Keratocytes, donor1	11527-119I6	299.82	24.41	11.35	0.34	1.03	1.03	0.69	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	223.81	8.20	4.69	0.00	1.17	0.00	0.00	0.00	1.17	1.17
Keratocytes, donor3	11688-122I5	106.31	8.30	4.54	1.19	0.59	0.20	0.40	0.20	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	296.72	0.00	6.59	0.00	0.00	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	267.53	58.25	9.71	0.00	6.47	3.24	2.16	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	91.00	32.64	3.58	0.92	0.69	0.12	1.96	1.85	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	539.56	107.57	9.99	1.51	0.81	1.01	1.72	1.61	0.50	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	169.92	11.50	7.83	0.59	0.47	0.83	0.71	0.59	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	106.89	5.58	3.07	0.84	0.84	0.28	0.56	0.56	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	102.32	11.49	5.82	1.42	0.16	0.63	0.63	0.16	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	122.06	9.14	7.53	0.54	0.00	0.54	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	112.83	6.62	6.62	0.00	1.89	0.00	0.32	0.32	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	96.17	10.24	5.18	0.75	1.19	0.54	0.11	0.11	0.54	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	101.37	10.26	3.69	1.64	1.64	0.00	0.41	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	132.98	8.60	3.79	0.51	0.76	0.00	0.51	0.51	0.25	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	126.11	8.45	6.19	0.56	0.56	0.42	0.70	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	199.35	5.93	3.16	1.58	0.79	0.00	0.40	0.40	1.98	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	174.88	4.65	3.49	0.78	1.74	0.39	0.19	0.19	0.00	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	103.31	8.52	4.44	0.56	0.74	0.56	0.37	0.19	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	133.10	5.92	6.97	0.70	2.09	1.05	0.70	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	171.98	7.87	4.05	2.15	0.24	0.95	0.48	0.00	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	125.12	9.89	4.26	0.41	0.96	0.69	0.27	0.14	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	165.07	7.08	6.16	1.23	1.23	1.85	0.00	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	109.42	4.36	2.18	0.62	1.87	0.31	0.00	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	150.60	10.43	5.49	1.28	0.73	0.18	0.37	0.00	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	129.67	9.22	2.96	0.99	0.66	0.00	0.00	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	159.03	5.27	5.56	0.59	0.59	0.29	0.88	0.00	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	140.40	14.69	3.73	0.75	0.75	0.25	1.00	0.50	1.49	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	161.98	7.76	5.82	0.97	0.48	0.48	0.48	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	190.39	5.92	4.85	0.27	0.81	0.81	0.00	0.54	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	128.22	12.56	4.54	0.76	0.61	1.06	0.45	0.15	0.61	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	162.78	8.29	3.63	0.52	0.52	1.04	0.52	0.00	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	201.64	5.86	5.03	1.68	1.47	1.47	0.21	0.00	0.63	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	140.30	10.83	4.81	1.50	1.20	1.20	0.15	0.75	0.60	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	220.81	7.57	7.57	0.69	2.06	0.69	0.69	0.69	1.38	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	189.84	4.33	4.14	0.94	0.56	1.13	0.00	0.00	0.94	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	138.47	9.33	5.30	0.85	0.74	1.06	0.53	0.00	0.85	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	198.68	6.78	5.33	1.94	1.45	0.48	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	241.81	6.28	5.29	1.32	0.66	0.99	0.00	0.33	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	150.40	11.03	4.34	0.74	1.49	0.62	0.37	0.12	0.37	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	140.31	8.51	4.81	0.74	0.37	0.74	0.00	0.37	1.48	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	192.48	5.44	2.96	0.74	0.99	0.74	0.25	0.49	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	134.47	7.97	4.26	1.24	1.10	0.55	0.00	0.14	0.55	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	145.38	7.40	3.54	0.96	0.32	0.96	0.64	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	250.77	7.00	6.39	0.61	1.22	0.91	0.30	0.61	1.22	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	132.41	9.80	4.34	0.84	0.98	0.56	0.42	0.28	0.42	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	154.67	6.40	3.56	0.00	0.36	0.71	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	324.32	7.76	3.88	0.48	1.94	0.48	1.45	0.00	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	156.23	10.27	5.14	0.62	0.93	1.09	0.62	0.00	1.09	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	156.85	6.80	3.58	1.07	1.79	0.36	0.36	0.36	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	327.33	5.88	7.51	0.98	1.63	0.00	0.33	0.33	0.33	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	122.18	12.24	4.71	0.94	1.41	0.47	0.47	0.47	0.94	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	294.78	10.52	9.53	0.25	1.49	1.11	0.74	0.25	0.37	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	283.28	5.38	4.87	1.79	0.77	1.54	0.26	0.26	0.26	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	146.79	8.65	4.77	0.30	0.90	1.49	0.00	0.60	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	27.19	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	36.06	0.00	0.77	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	34.88	0.00	0.00	0.00	1.48	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	70.24	56.70	0.42	3.81	0.00	1.27	0.00	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.20	50.64	0.70	2.11	1.41	0.70	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	44.83	37.36	0.93	0.93	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	48.95	65.95	0.52	2.58	0.52	1.03	0.00	0.00	1.55	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	48.77	48.77	0.00	1.19	0.00	0.00	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.04	52.70	0.23	0.00	0.23	0.23	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	96.55	58.46	0.29	2.04	0.58	1.16	0.00	0.00	2.91	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	67.53	64.83	0.00	1.80	1.35	0.45	0.00	0.00	1.80	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	91.99	87.52	0.14	1.63	0.14	0.14	0.00	0.00	0.95	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	93.46	77.03	0.51	3.08	1.54	0.51	0.00	0.00	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	67.75	61.04	0.35	2.82	0.71	1.06	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	77.29	69.30	0.00	1.33	2.00	0.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	86.09	83.54	0.00	1.53	0.00	0.00	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	82.18	62.70	0.27	1.87	0.80	0.80	0.00	0.00	1.60	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	91.64	65.56	0.00	1.70	1.13	0.57	0.00	0.00	0.94	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	111.67	69.95	0.00	1.23	2.45	1.23	0.00	0.00	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	85.62	81.54	0.00	1.63	2.45	0.82	0.00	0.00	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	98.08	66.64	0.42	2.08	1.25	2.08	0.00	0.00	1.25	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	110.42	60.26	0.28	4.48	3.08	0.28	0.00	0.00	2.24	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	91.70	76.25	0.00	1.03	1.03	1.03	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	100.74	70.25	0.29	3.19	1.45	1.45	0.00	0.29	2.03	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	94.76	51.71	0.00	1.49	1.20	0.30	0.00	0.30	0.30	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	73.58	48.13	0.00	1.66	1.11	1.66	0.00	0.00	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	141.75	89.08	0.00	3.53	2.83	1.41	0.00	0.00	1.77	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	108.79	74.12	0.00	2.58	2.58	0.74	0.00	0.00	2.21	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	89.80	71.38	0.00	1.15	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	123.95	81.36	0.00	1.54	1.54	1.92	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	132.47	95.11	0.00	6.79	2.26	1.13	0.00	0.00	2.26	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	109.12	82.87	0.00	1.64	2.46	0.00	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	137.82	97.61	0.45	4.07	3.16	0.45	0.00	0.00	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	138.60	70.38	0.00	1.44	2.15	1.44	0.00	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	129.21	74.69	0.00	1.49	0.75	0.75	0.00	0.00	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	109.25	85.84	0.37	2.60	2.60	2.97	0.00	0.00	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	93.90	53.84	0.00	2.58	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	93.34	59.08	0.00	0.86	0.86	5.14	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	107.62	78.30	0.33	2.33	1.67	1.00	0.00	0.00	0.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	88.69	65.16	0.00	1.81	0.60	1.81	0.00	0.00	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	68.26	61.86	0.71	0.71	0.00	0.71	0.00	0.00	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	86.27	77.68	0.00	1.37	0.69	1.03	0.00	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	107.35	69.78	0.00	1.07	3.22	0.00	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	82.82	57.91	0.00	0.00	0.67	0.67	0.00	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	105.20	74.82	0.00	2.22	2.22	0.74	0.00	0.00	2.59	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	48.84	43.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	79.33	48.66	0.00	3.17	0.00	0.00	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	107.64	94.84	0.40	2.80	2.00	1.60	0.00	0.00	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	69.05	65.42	0.00	0.00	0.00	0.00	0.00	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.22	56.72	0.77	3.07	0.77	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	60.67	76.46	0.49	2.96	1.48	0.49	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	104.44	72.45	0.00	2.82	0.00	0.00	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	65.37	60.84	0.00	2.01	1.01	0.50	0.00	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	102.29	77.06	0.45	1.35	0.00	1.80	0.00	0.00	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	134.25	96.38	0.00	1.72	0.00	0.00	0.00	0.00	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	124.70	108.66	0.00	3.12	1.78	0.45	0.00	0.00	2.23	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	116.53	97.76	0.00	3.13	0.78	0.78	0.00	0.00	2.35	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	118.75	85.77	0.00	1.98	3.96	1.32	0.00	0.00	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	114.68	101.71	0.52	0.52	1.04	0.00	0.00	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	123.83	98.89	0.00	2.19	0.88	1.31	0.00	0.00	3.50	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	162.70	91.13	0.56	2.80	1.12	2.80	0.00	0.00	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	153.25	103.34	0.00	2.65	1.32	1.32	0.00	0.00	2.21	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	127.67	104.14	0.39	4.63	1.93	0.77	0.39	0.00	2.31	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	203.05	112.41	0.00	2.53	2.53	0.51	0.00	0.00	5.06	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	180.71	98.53	0.00	2.40	1.92	1.44	0.00	0.00	0.96	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	155.84	105.35	0.40	5.17	2.78	1.59	0.00	0.00	2.78	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	260.06	124.56	0.00	4.86	4.86	1.82	0.00	0.00	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	194.37	118.28	0.69	3.46	0.00	2.08	0.00	0.00	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	220.01	139.84	0.00	4.56	2.66	2.28	0.00	0.00	3.80	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	273.70	134.78	0.00	6.20	4.65	3.61	0.00	0.00	1.03	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	211.63	165.07	0.00	5.44	3.02	2.42	0.00	0.00	4.23	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	187.92	121.06	0.32	3.49	2.85	2.54	0.00	0.00	1.90	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	308.66	165.26	1.07	4.26	4.26	1.60	0.00	0.00	2.67	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	245.38	180.45	0.57	6.90	3.45	0.00	0.57	0.00	2.87	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	320.37	176.90	0.00	5.14	6.69	3.60	0.00	0.00	4.11	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	399.65	187.45	0.00	5.66	7.07	5.66	0.00	0.00	6.37	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	322.33	228.13	0.00	8.51	3.40	2.84	0.00	0.00	5.11	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	291.63	168.91	0.00	6.24	4.16	1.66	0.00	0.00	3.74	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	517.59	215.34	0.00	8.61	3.13	2.35	0.00	0.00	6.26	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	354.91	227.98	0.00	3.76	3.76	3.34	0.00	0.00	4.18	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	324.32	217.45	0.00	6.04	4.18	5.11	0.00	0.00	4.18	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	380.69	159.90	0.00	4.01	6.69	2.68	0.00	0.00	4.68	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	355.00	195.68	0.00	3.74	4.28	0.53	0.00	0.00	4.28	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	367.73	202.05	0.40	10.10	4.85	2.02	0.00	0.00	6.87	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	271.66	136.75	0.00	5.51	1.84	0.92	0.00	0.00	4.59	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	259.62	168.04	0.00	4.45	2.67	4.45	0.00	0.00	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	286.64	153.86	0.00	5.70	3.99	1.71	0.00	0.00	3.42	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	232.37	89.73	1.53	3.07	0.00	0.77	0.00	0.00	2.30	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	243.49	114.91	0.55	4.92	1.09	3.28	0.00	0.00	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	226.29	104.68	0.00	3.56	1.34	1.34	0.00	0.00	2.67	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	172.35	98.78	0.26	1.30	1.04	1.56	0.00	0.00	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	164.45	86.20	1.33	1.99	1.99	2.65	0.00	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	191.23	103.93	0.00	0.00	2.08	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	57.89	7.52	1.37	0.00	0.23	0.00	0.00	0.00	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	263.52	12.29	10.64	1.28	1.10	1.65	0.18	0.00	0.55	0.92
Macrophage - monocyte derived, donor3	11389-118C3	183.12	18.61	6.42	0.92	0.92	0.79	0.13	0.13	0.66	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	69.03	0.53	1.06	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	324.99	4.75	5.86	1.27	1.27	0.79	0.00	0.00	1.11	0.32
Mallassez-derived cells, donor3	11930-125I4	224.33	4.45	2.78	1.53	0.42	0.14	0.00	0.00	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	90.97	2.99	1.20	0.20	0.60	0.00	0.00	0.00	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	92.95	4.34	2.03	0.29	0.58	0.29	0.00	0.00	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	125.46	4.24	1.25	0.25	1.00	0.50	0.00	0.00	0.50	1.00
Mast cell - stimulated, donor1	11487-119E2	4122.53	763.36	12.20	42.03	3.39	29.83	2.71	2.03	13.56	18.30
Mast cell, donor1	11563-120D6	639.76	175.08	8.65	5.52	3.03	6.70	1.41	0.65	3.03	3.24
Mast cell, donor2	11565-120D8	4112.00	76.67	53.49	45.76	8.62	49.03	5.35	5.05	12.18	36.85
Mast cell, donor3	11566-120D9	2824.19	58.98	44.80	26.56	7.43	18.91	4.50	2.03	13.28	21.16
Mast cell, donor4	11567-120E1	2657.56	49.29	42.90	23.40	6.03	31.91	3.19	3.72	9.22	23.22
Mast cell, expanded and stimulated, donor5	11940-126A5	286.21	166.45	17.96	2.33	1.89	2.55	0.67	0.44	1.22	2.22
Mast cell, expanded and stimulated, donor8	11942-126A7	618.70	82.30	9.34	1.75	2.92	4.09	0.58	0.58	1.17	5.84
Mast cell, expanded, donor5	11939-126A4	132.73	104.28	6.19	1.49	1.15	1.95	0.23	0.11	1.15	1.95
Mast cell, expanded, donor8	11941-126A6	126.03	66.11	10.04	2.85	0.84	3.01	0.17	0.17	1.00	2.34
Melanocyte - dark, donor1	11502-119F8	199.89	10.15	8.46	0.60	0.80	0.30	0.60	0.60	0.50	0.30
Melanocyte - dark, donor2	11582-120F7	190.69	49.49	3.81	0.69	2.77	1.38	1.38	0.35	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	117.57	5.07	19.34	0.22	0.29	0.07	0.29	0.29	0.07	0.22
Melanocyte - light, donor1	11274-116H5	189.00	5.88	28.21	0.71	0.94	0.71	0.71	0.24	0.47	1.88
Melanocyte - light, donor2	11351-117H1	124.21	7.51	15.70	1.36	0.68	0.00	0.00	0.00	0.00	2.05
Melanocyte - light, donor3	11423-118G1	88.46	6.07	4.34	0.00	0.87	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	108.08	8.85	10.93	0.52	0.73	0.83	0.10	0.31	0.31	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	68.58	3.77	8.34	0.54	0.27	0.27	0.81	0.27	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	120.80	13.39	17.41	1.34	1.87	0.54	0.27	0.80	0.80	1.34
Meningeal Cells, donor1	11493-119E8	387.69	44.41	20.97	1.12	0.99	1.24	1.98	1.61	1.12	0.37
Meningeal Cells, donor2	11573-120E7	125.88	86.27	9.24	1.76	0.88	2.20	1.76	0.88	0.00	0.44
Meningeal Cells, donor3	11654-122E7	241.98	20.05	10.02	0.41	1.14	0.49	1.22	0.57	0.33	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	123.76	15.40	6.27	0.29	0.57	0.00	0.00	0.57	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	296.46	50.52	6.24	1.81	1.01	1.01	0.60	0.40	1.21	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	799.01	14.46	26.28	1.31	1.31	0.00	3.94	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	323.12	17.01	9.16	1.31	1.31	1.31	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	271.25	10.76	5.74	2.87	0.72	2.15	0.00	0.00	0.72	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	718.95	27.74	10.80	6.35	4.24	5.08	0.64	0.42	3.18	3.18
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	561.46	33.68	4.52	5.03	4.52	4.52	0.50	0.00	3.02	6.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	264.80	24.39	7.47	0.88	1.32	0.66	0.00	0.22	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	181.92	8.04	9.50	0.00	0.73	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	235.29	19.03	6.34	1.02	1.43	0.20	0.61	0.61	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	221.61	27.70	8.86	0.69	1.25	0.83	1.80	0.55	0.42	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	637.14	98.14	15.24	2.23	2.60	4.09	0.74	0.37	1.49	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	580.37	68.29	11.18	1.32	2.76	1.18	0.79	0.39	1.05	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	189.32	90.21	8.31	1.78	0.89	0.89	0.00	0.30	0.89	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	207.86	56.05	7.01	4.67	0.00	0.00	0.00	0.00	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	196.60	64.04	8.33	0.64	2.56	0.64	1.28	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	269.38	13.47	7.09	0.00	1.42	1.06	0.00	0.00	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	331.49	48.16	7.19	1.56	0.94	0.94	0.00	0.00	1.56	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	91.44	37.01	4.35	1.45	1.45	0.00	0.73	0.73	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	297.53	69.21	9.55	1.59	2.39	2.39	0.27	0.00	1.06	3.98
Mesothelial Cells, donor2	12156-128G5	314.79	57.05	5.00	1.00	1.50	0.50	0.00	0.00	1.50	1.00
Mesothelial Cells, donor3	11402-118D7	312.18	59.33	10.55	3.32	2.53	3.11	0.58	0.36	3.25	3.04
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	471.26	47.26	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	235.44	29.80	2.46	0.49	0.49	1.23	0.00	0.00	1.48	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	221.73	10.60	2.65	0.29	1.18	1.18	0.00	0.00	0.29	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	93.34	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	124.60	15.81	1.24	1.24	0.62	0.62	0.31	0.00	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	162.42	9.33	3.11	0.21	0.83	0.21	0.21	0.00	0.83	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	97.27	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	204.71	25.53	3.25	2.00	1.00	0.25	0.00	0.00	1.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	249.03	10.71	3.26	0.00	0.47	0.93	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	188.18	22.15	3.05	0.81	0.61	1.22	0.00	0.00	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	176.20	8.71	2.38	0.40	0.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	159.29	24.78	0.88	0.88	0.00	0.88	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	146.66	7.98	3.04	0.00	1.14	1.14	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	68.43	13.16	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	134.55	17.83	1.49	0.64	0.21	0.85	0.00	0.00	1.06	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	157.46	7.37	2.76	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	135.62	11.03	1.79	0.60	0.60	0.60	0.00	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	134.13	3.35	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	124.95	11.79	1.25	0.25	0.00	0.75	0.00	0.00	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	134.76	5.94	2.61	0.24	1.19	0.00	0.00	0.00	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.36	1.11	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	126.40	11.51	1.61	0.23	0.92	0.23	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	153.55	6.31	1.68	0.84	0.42	0.21	0.00	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	119.65	11.01	0.41	0.61	0.20	0.61	0.00	0.20	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	124.43	13.30	1.50	0.43	0.21	1.50	0.00	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	149.82	4.00	2.00	0.00	0.89	0.22	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	128.12	8.10	1.97	0.88	1.10	0.22	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	186.56	4.06	0.51	0.51	0.00	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	91.13	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	153.83	14.13	1.63	1.63	0.27	0.00	0.00	0.00	0.54	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	178.21	5.88	1.76	0.29	0.59	0.29	0.00	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	87.23	6.54	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	96.59	6.73	0.48	1.44	0.00	0.00	0.00	0.00	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	144.08	6.00	0.40	0.00	0.40	0.40	0.00	0.00	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	123.41	4.11	2.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	102.12	7.01	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	118.23	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	95.90	3.94	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	119.19	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	126.16	4.48	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	133.63	6.69	0.25	0.50	0.25	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	153.10	2.09	1.39	0.00	0.00	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	55.25	6.63	0.00	0.00	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	125.47	7.18	0.68	0.68	1.71	0.34	0.00	0.00	0.34	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	145.29	2.19	1.75	0.44	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	80.96	3.20	1.07	0.00	0.00	0.00	0.00	0.00	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	118.67	7.29	0.56	1.12	0.84	0.56	0.00	0.00	1.40	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	103.91	2.49	0.00	0.42	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	80.42	2.33	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	96.23	5.13	0.30	0.30	0.00	1.81	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	102.68	3.76	0.83	0.83	0.83	1.67	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	93.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	88.66	4.62	2.77	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	122.36	3.41	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	84.43	4.28	1.38	0.00	0.00	0.14	0.14	0.00	0.41	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	87.85	5.18	0.78	1.55	0.26	0.00	0.00	0.00	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	121.83	2.57	3.43	0.00	0.43	0.00	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	68.60	2.54	2.54	0.00	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	83.54	4.27	0.53	0.27	0.00	0.27	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	116.44	16.46	2.69	1.20	0.00	0.60	0.30	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	64.27	4.52	1.13	0.14	0.14	0.14	0.28	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	87.91	6.05	1.27	1.27	0.64	0.64	0.00	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	81.38	2.87	2.21	0.00	0.00	0.22	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	85.70	5.69	3.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	86.65	5.40	1.14	0.57	0.00	0.28	0.00	0.00	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.22	2.70	1.23	0.49	0.25	0.25	0.00	0.00	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	67.77	8.47	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	125.55	7.64	2.06	0.88	0.29	0.59	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	107.55	6.63	2.88	0.86	0.00	0.58	0.00	0.00	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	174.75	37.51	5.36	1.24	0.00	0.41	0.00	0.41	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	87.85	15.19	5.36	0.60	0.00	0.30	0.30	0.00	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	65.94	12.48	0.00	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	63.09	17.09	1.64	0.33	0.66	0.00	0.00	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	224.07	16.83	5.26	1.05	0.00	2.10	0.00	0.00	4.21	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	80.85	6.33	0.59	0.40	0.59	0.20	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	330.62	10.24	3.73	1.86	0.00	0.93	0.00	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	197.90	18.40	1.50	3.76	1.13	0.38	0.00	0.00	1.88	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	268.74	15.18	4.26	1.60	1.86	0.80	0.27	0.00	1.33	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	53.38	11.20	0.90	0.11	0.11	0.00	0.00	0.00	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	216.60	14.73	2.21	0.00	1.47	0.74	0.00	0.00	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	71.82	18.32	0.73	0.00	1.47	0.00	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	258.23	34.22	1.56	3.11	3.11	4.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	81.23	6.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	193.20	19.32	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	123.21	22.22	0.00	0.00	2.02	1.01	0.00	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	224.31	14.76	2.53	2.11	1.26	0.84	0.00	0.00	1.26	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	70.57	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	38.06	1.62	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	75.52	0.00	1.51	0.00	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	6.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	341.04	18.53	4.96	1.72	3.66	2.80	0.00	0.22	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	316.70	4.70	9.93	4.18	2.09	2.09	1.05	0.52	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	359.11	10.68	10.01	2.00	3.34	2.00	1.33	0.00	3.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	276.72	13.36	7.51	0.83	0.83	1.67	0.42	0.00	0.42	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	187.10	9.70	3.23	1.14	0.19	1.33	0.38	0.19	0.76	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	510.67	22.34	19.15	0.00	1.60	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	193.78	10.88	12.92	0.00	0.00	1.36	0.00	0.68	4.08	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	0.00	1.84	0.00	0.00	1.84	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	132.26	14.65	8.37	0.84	0.00	1.67	1.26	0.84	0.84	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	146.44	13.25	5.58	1.39	0.23	0.70	0.00	0.00	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	166.46	12.70	8.11	1.35	1.08	2.16	1.08	0.81	0.81	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	201.62	10.93	13.46	1.47	0.00	0.84	1.05	0.84	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	127.56	8.44	8.44	0.00	1.99	2.98	0.50	0.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	77.95	6.23	6.23	0.54	0.00	0.27	0.27	0.27	0.00	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	144.40	13.37	5.89	2.49	1.36	0.91	0.68	0.00	0.45	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	133.74	8.33	7.35	0.65	0.33	0.82	0.65	0.65	0.49	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	185.90	14.40	12.58	1.82	0.18	1.64	0.36	0.91	0.73	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	143.75	12.20	5.83	2.12	1.06	1.06	0.53	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	134.47	6.60	6.60	0.60	1.80	1.80	0.00	0.00	0.00	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	104.36	11.16	2.30	1.31	0.98	1.31	0.98	0.98	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	129.45	11.55	5.04	1.63	1.14	0.98	0.16	0.33	1.14	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	365.64	22.05	21.17	2.12	1.76	1.23	1.06	0.53	1.94	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	134.32	11.95	5.63	2.81	0.00	2.11	0.00	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	136.99	11.95	10.57	1.84	0.92	0.00	0.92	0.00	0.92	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	94.15	12.85	9.32	0.96	0.64	1.29	0.64	0.32	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	101.05	16.21	3.45	2.07	2.76	1.38	0.00	0.00	1.03	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	60.68	5.06	0.00	0.00	2.53	0.00	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	302.76	17.15	14.93	0.67	0.89	0.67	1.34	0.45	0.22	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	102.46	11.01	2.96	1.27	1.27	3.81	0.42	0.85	2.54	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	107.52	7.83	7.12	1.19	1.19	1.19	0.24	0.24	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	108.17	15.88	8.58	1.72	0.86	2.58	1.29	0.86	0.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	9.03	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	119.29	11.66	9.66	0.00	1.33	1.00	0.33	0.33	0.33	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	368.35	29.76	17.58	0.45	2.71	0.00	1.35	0.90	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	132.53	18.25	3.57	1.98	0.79	0.79	0.79	0.79	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	127.22	13.93	8.36	2.79	0.93	0.00	0.00	0.00	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	73.03	11.73	4.54	0.76	0.38	1.51	1.14	0.00	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	113.41	17.92	4.89	0.98	1.30	0.33	0.33	0.33	0.98	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	101.97	14.82	11.77	0.00	0.44	0.00	0.87	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	361.83	25.78	15.38	2.26	0.45	1.36	0.45	1.81	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	187.85	16.76	2.65	3.53	1.76	0.88	0.88	0.88	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	110.36	7.98	3.99	1.99	1.99	1.99	0.00	0.00	1.33	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	159.23	14.39	8.93	0.99	1.49	1.49	1.98	0.00	1.98	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	118.68	22.20	9.57	1.91	1.15	0.77	0.00	0.00	0.38	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	88.31	11.19	9.07	1.81	0.00	1.81	0.91	0.30	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	229.20	20.33	10.83	0.66	1.11	1.33	0.44	0.44	0.88	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	115.20	14.23	5.42	0.68	0.00	1.36	2.03	0.00	0.00	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	95.72	9.15	7.32	0.00	0.00	0.61	0.61	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	90.01	14.79	8.81	0.94	1.89	0.63	0.31	0.31	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	82.62	9.38	10.29	0.61	0.61	1.51	0.61	0.30	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	248.42	22.15	15.82	3.96	2.37	3.16	1.58	0.00	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	39.68	5.67	1.13	3.40	0.00	2.27	1.13	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	225.35	13.54	3.73	0.87	1.61	1.99	0.00	0.00	0.99	0.62
Myoblast, donor2	11322-117D8	143.27	12.27	7.48	1.34	1.34	0.38	0.38	0.00	1.73	0.77
Myoblast, donor3	11398-118D3	214.91	6.39	6.22	0.17	0.67	1.18	0.50	0.00	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.82	5.98	0.58	0.15	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	680.84	17.22	9.84	0.92	2.15	2.15	0.00	0.00	1.54	1.85
Natural Killer Cells, donor2	11311-117C6	634.78	14.47	9.65	3.62	1.81	3.02	0.00	0.00	2.11	3.62
Natural Killer Cells, donor3	11387-118C1	635.72	21.17	8.47	1.84	1.66	2.39	0.18	0.55	1.47	1.29
Neural stem cells, donor1	11275-116H6	300.88	9.07	18.15	2.18	0.00	3.63	2.54	2.90	2.90	0.36
Neural stem cells, donor2	11352-117H2	417.86	7.70	15.41	3.85	0.00	3.85	15.41	26.96	0.00	0.00
Neurons, donor1	11494-119E9	104.69	6.83	6.83	0.00	1.14	1.14	9.10	5.69	0.00	0.00
Neurons, donor2	11574-120E8	35.67	5.28	7.71	0.00	0.44	0.00	6.83	11.67	0.66	0.00
Neurons, donor3	11655-122E8	92.08	7.40	5.76	0.00	0.82	1.64	6.58	5.76	1.64	0.00
Neutrophils, donor1	11233-116C9	2392.40	895.52	21.34	22.27	27.84	19.49	0.00	0.00	13.92	15.78
Neutrophils, donor2	11314-117C9	1359.57	817.48	8.70	40.58	34.79	55.08	0.00	0.00	28.99	17.39
Neutrophils, donor3	11390-118C4	3195.32	990.79	24.43	35.43	7.94	20.16	0.61	0.00	9.77	18.94
Nucleus Pulposus Cell, donor1	11252-116F1	235.57	52.48	17.10	1.54	1.42	0.95	1.78	1.78	0.36	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	116.57	25.07	5.86	0.65	0.33	1.30	0.33	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	120.93	14.24	8.02	0.60	0.40	0.40	0.60	0.80	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	595.48	25.19	12.94	6.06	5.64	6.19	1.38	0.96	4.82	2.62
Olfactory epithelial cells, donor2	11934-125I8	461.01	33.44	9.41	6.95	7.24	5.50	0.29	0.14	3.62	2.32
Olfactory epithelial cells, donor3	11935-125I9	380.47	14.19	14.30	3.41	3.29	2.27	0.68	0.45	1.93	1.02
Olfactory epithelial cells, donor4	11936-126A1	742.26	26.78	19.09	4.38	3.99	3.80	1.56	1.07	3.31	2.34
Oligodendrocyte - precursors, donor1	11496-119F2	420.67	31.29	6.62	1.20	0.60	0.00	0.60	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	203.34	7.44	12.12	1.06	2.34	2.13	1.06	1.49	0.21	1.49
Osteoblast - differentiated, donor2	11353-117H3	51.44	11.43	5.72	1.14	0.00	4.57	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	114.21	6.21	10.55	0.62	1.86	1.24	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	177.46	21.11	5.08	0.98	0.59	0.20	0.59	0.20	0.78	0.00
Osteoblast, donor2	11354-117H4	419.28	49.86	9.13	0.70	4.21	0.70	2.11	2.11	2.81	0.00
Osteoblast, donor3	11426-118G4	265.00	17.77	6.58	1.60	0.18	0.89	1.24	0.36	1.07	0.18
Pancreatic stromal cells, donor1	11249-116E7	352.36	10.78	8.51	2.61	2.53	3.20	0.42	0.08	1.43	2.53
Pericytes, donor1	11491-119E6	214.74	17.36	25.59	1.11	1.45	1.00	6.23	4.67	0.67	0.89
Pericytes, donor2	11571-120E5	239.95	20.37	16.07	2.26	2.72	3.17	3.85	3.17	1.81	1.36
Pericytes, donor3	11652-122E5	508.62	40.89	7.93	2.64	3.05	1.83	0.00	0.20	3.26	1.83
Perineurial Cells, donor1	11499-119F5	138.34	18.08	8.59	0.23	1.24	0.68	0.79	0.68	0.45	0.34
Perineurial Cells, donor2	11579-120F4	273.73	67.44	4.51	1.47	0.74	1.38	0.46	0.55	0.55	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	749.68	65.98	11.79	1.91	2.87	2.23	0.00	0.00	1.27	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	626.85	76.89	3.67	4.90	5.14	3.92	0.00	0.24	4.16	3.43
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	430.82	41.28	5.56	2.46	2.46	2.33	0.26	0.00	1.68	2.72
Placental Epithelial Cells, donor1	11278-116H9	96.62	4.07	0.00	0.72	0.00	0.24	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	134.18	9.98	2.22	1.11	0.00	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	118.58	10.41	0.98	0.98	1.18	0.39	0.00	0.00	0.79	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	393.67	34.18	5.06	7.59	3.80	3.80	0.00	0.00	4.43	2.85
Preadipocyte - breast, donor1	11467-119B9	396.94	24.01	10.32	2.06	1.13	1.88	0.00	0.56	1.50	4.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	760.19	19.45	8.75	1.96	2.61	3.92	0.39	0.39	1.83	0.78
Preadipocyte - breast, donor2	11328-117E5	366.99	25.22	6.98	5.40	5.18	5.63	0.45	0.45	4.05	3.83
Preadipocyte - omental, donor1	11468-119C1	337.26	28.77	7.57	3.09	1.39	3.41	0.21	0.11	1.07	3.09
Preadipocyte - omental, donor2	11329-117E6	692.24	31.43	12.66	1.75	2.62	2.18	0.00	0.87	3.06	3.49
Preadipocyte - omental, donor3	11403-118D8	422.44	42.54	5.44	4.30	4.15	6.59	0.14	0.14	2.72	3.44
Preadipocyte - perirenal, donor1	11469-119C2	220.48	22.64	0.98	3.94	0.98	1.97	0.00	0.98	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	663.68	48.83	9.52	3.69	0.61	1.23	2.15	0.00	0.61	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	487.14	52.06	9.39	5.67	5.67	2.48	0.35	0.18	4.25	2.30
Preadipocyte - subcutaneous, donor3	11428-118G6	357.94	38.48	7.32	2.89	2.38	3.58	0.34	0.17	2.21	4.60
Preadipocyte - visceral, donor1	11280-116I2	646.63	36.42	13.32	3.63	3.07	2.51	0.84	0.47	1.30	2.51
Preadipocyte - visceral, donor2	11357-117H7	581.21	27.61	14.73	3.68	6.44	3.68	0.92	0.00	4.60	1.84
Preadipocyte - visceral, donor3	11429-118G7	434.68	29.88	8.46	4.08	4.08	4.39	0.21	0.31	3.76	3.03
Prostate Epithelial Cells (polarized), donor1	11253-116F2	185.40	31.38	0.15	3.17	1.96	3.47	0.15	0.00	0.75	2.56
Prostate Epithelial Cells, donor2	11331-117E8	301.43	29.25	3.66	6.77	4.60	5.28	0.00	0.14	2.84	5.42
Prostate Epithelial Cells, donor3	11404-118D9	56.46	2.02	0.18	1.16	0.80	1.04	0.00	0.00	0.43	0.43
Prostate Stromal Cells, donor1	11254-116F3	388.29	39.75	4.67	2.85	3.19	2.62	0.46	0.23	1.37	3.30
Prostate Stromal Cells, donor2	11332-117E9	339.77	41.06	6.28	4.12	4.30	3.23	0.36	0.00	3.94	2.87
Prostate Stromal Cells, donor3	11405-118E1	304.80	36.39	6.88	3.65	4.59	4.38	0.52	0.52	2.09	3.96
Renal Cortical Epithelial Cells, donor1	11516-119H4	351.84	43.07	16.42	1.46	2.19	2.55	0.73	0.00	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	298.87	21.21	8.53	0.55	1.11	0.76	0.55	0.28	0.35	0.62
Renal Epithelial Cells, donor1	11517-119H5	551.87	92.32	31.96	1.52	1.01	2.03	0.51	0.00	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	285.24	39.83	8.54	2.13	0.00	1.42	1.42	0.00	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	374.87	24.14	11.33	0.95	1.16	0.95	0.32	0.53	0.64	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	224.00	19.74	12.26	2.04	2.04	2.04	0.68	0.00	4.77	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	305.51	13.75	16.17	2.56	1.48	3.77	0.27	0.40	1.75	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	302.16	34.19	6.66	1.11	1.11	0.67	1.55	0.89	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	466.48	62.55	15.97	2.66	2.00	5.32	0.67	1.33	2.66	2.00
Renal Mesangial Cells, donor1	11518-119H6	608.10	50.40	22.23	2.64	4.18	2.20	1.98	3.52	1.54	2.64
Renal Mesangial Cells, donor2	11598-120H5	300.95	31.35	11.91	3.13	0.63	1.88	1.25	3.13	1.88	1.25
Renal Mesangial Cells, donor3	11679-122H5	296.83	45.50	14.43	0.83	1.94	1.39	2.77	0.83	1.11	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	362.10	42.41	7.52	1.61	1.88	0.81	0.27	0.27	0.54	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	201.57	22.35	5.48	0.84	1.69	1.69	0.00	0.42	0.42	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	290.43	43.78	7.91	1.93	2.12	1.54	0.58	1.54	0.77	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	77.53	49.52	1.04	0.52	1.04	0.00	0.00	0.00	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	125.64	89.25	5.97	0.85	0.85	0.28	0.85	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	147.16	76.16	6.17	0.00	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	162.34	29.61	6.27	0.25	1.25	1.00	0.75	1.00	0.00	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	199.65	23.12	3.61	1.60	1.47	1.47	0.00	0.00	0.80	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	24.12	0.89	0.00	0.89	0.00	0.00	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	105.67	48.98	1.10	1.65	1.10	2.20	0.00	0.00	0.55	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	159.52	50.46	4.06	1.16	1.16	2.32	0.00	0.00	0.58	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	50.06	43.43	0.78	0.13	0.26	0.13	0.00	0.00	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.41	31.68	0.89	0.60	0.40	0.20	0.00	0.00	0.30	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	47.85	32.35	1.78	0.22	0.00	0.33	0.22	0.11	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	42.79	32.13	0.99	0.37	0.87	0.50	0.00	0.00	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	51.28	39.63	1.05	0.47	0.70	0.82	0.00	0.12	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	58.01	40.68	1.85	0.92	0.69	0.23	0.00	0.00	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.64	40.80	1.64	0.27	0.55	0.27	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	55.06	37.36	1.51	0.45	0.45	0.61	0.15	0.00	0.91	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.49	25.80	1.25	0.00	0.00	0.00	0.36	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	58.10	37.01	1.00	0.29	0.57	0.86	0.00	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.12	33.59	1.07	1.07	0.43	0.32	0.00	0.11	0.64	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	43.59	32.31	2.43	0.00	0.44	1.33	0.00	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	73.79	44.54	1.53	0.57	0.19	0.38	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	50.59	36.80	1.02	0.19	0.37	0.65	0.28	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	86.63	48.67	1.50	0.56	0.19	0.56	0.00	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	72.33	49.23	1.59	0.00	0.00	0.13	0.13	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	50.81	37.57	1.27	0.78	0.68	0.49	0.19	0.00	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	53.28	36.66	2.10	0.19	0.57	1.15	0.19	0.00	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	69.10	45.92	0.96	0.32	0.21	0.43	0.00	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	62.51	40.92	2.24	1.12	0.56	0.56	0.00	0.00	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	67.16	38.96	0.85	0.68	0.00	0.17	0.00	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	72.39	41.21	1.09	0.36	0.18	0.18	0.00	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.81	36.05	1.72	0.49	0.25	0.98	0.12	0.12	0.37	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	49.16	32.37	1.61	0.67	0.67	0.54	0.00	0.00	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	86.57	46.70	0.24	0.24	0.47	0.24	0.00	0.00	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.76	33.73	1.19	1.39	0.60	0.60	0.00	0.00	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.46	37.65	1.17	0.94	1.17	0.47	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	69.88	39.81	0.62	0.41	0.41	0.21	0.00	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	58.40	36.94	2.21	0.44	0.22	0.22	0.00	0.00	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	60.37	36.76	1.04	0.63	0.42	0.42	0.00	0.00	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	64.33	39.84	0.81	1.21	0.27	0.67	0.00	0.00	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.82	35.08	1.36	0.17	0.17	0.34	0.00	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	57.07	32.20	1.16	0.39	0.39	0.58	0.39	0.00	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	72.90	36.97	0.69	0.69	0.17	0.34	0.17	0.17	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	43.89	30.18	1.78	0.00	0.55	0.14	0.14	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	56.80	33.16	1.81	1.15	0.49	0.33	0.16	0.00	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	43.63	35.28	0.51	0.34	0.00	0.34	0.34	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.82	31.51	1.33	0.15	0.15	0.59	0.00	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	59.71	38.38	2.40	0.53	1.07	0.27	0.00	0.00	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	35.12	39.13	1.11	0.14	0.14	0.55	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	27.38	23.57	4.05	0.24	0.24	0.95	0.00	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	117.30	64.90	4.43	0.20	0.81	1.01	0.20	0.20	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	65.45	29.48	2.26	0.75	0.94	0.85	0.09	0.09	0.57	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	52.40	36.33	3.14	0.70	0.35	0.70	0.00	0.35	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.75	20.85	1.51	0.30	0.00	0.60	0.30	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	74.53	30.47	2.57	1.71	0.86	0.73	0.12	0.00	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	96.50	31.58	1.75	0.58	0.29	0.44	0.15	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	63.28	18.25	1.22	0.61	0.00	0.61	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	75.65	22.30	1.51	0.00	0.60	0.60	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	83.01	44.11	2.71	2.26	0.90	3.39	0.00	0.45	0.90	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	91.36	28.76	3.00	1.20	0.90	0.00	0.00	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	61.99	45.69	3.78	2.13	1.30	1.65	0.12	0.12	0.47	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	55.50	31.59	2.13	4.48	0.85	4.06	0.43	0.00	1.28	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	63.10	25.24	3.00	1.80	0.00	1.20	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	197.66	39.68	12.60	2.63	1.50	2.07	1.50	2.63	2.82	0.00
Schwann Cells, donor2	11578-120F3	146.30	20.41	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	153.58	21.91	10.08	0.44	0.88	1.10	2.63	1.31	0.44	0.22
Sebocyte, donor1	11220-116B5	443.15	3.83	11.50	0.55	0.55	1.10	0.00	0.00	2.19	0.00
Sebocyte, donor2	11301-117B5	220.59	8.27	4.60	2.30	1.38	0.00	0.00	0.00	2.30	1.84
Sebocyte, donor3	11378-118B1	172.52	13.81	10.92	2.89	1.03	0.62	0.41	0.00	0.82	1.44
Sertoli Cells, donor1	11255-116F4	468.82	66.26	9.94	6.63	4.97	3.31	0.00	1.66	1.66	6.63
Sertoli Cells, donor2	11333-117F1	434.95	39.54	8.47	5.65	5.65	5.65	0.00	0.00	5.65	8.47
Skeletal Muscle Cells, donor1	11281-116I3	312.32	9.94	15.31	2.64	1.85	2.46	1.23	1.76	0.97	3.78
Skeletal Muscle Cells, donor2	11358-117H8	208.90	9.40	9.40	2.17	2.17	2.17	0.72	0.00	2.89	0.72
Skeletal Muscle Cells, donor3	11430-118G8	277.56	21.74	9.20	5.85	1.67	0.00	3.34	1.67	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	147.83	20.42	4.24	0.94	0.79	1.89	0.16	0.16	1.26	0.47
Skeletal Muscle Cells, donor5	11455-119A6	131.40	21.55	5.35	0.89	1.34	1.49	0.59	0.15	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	195.15	20.16	5.23	1.54	0.77	1.39	0.77	0.15	1.69	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	165.07	21.55	8.44	1.26	0.76	1.13	0.63	0.63	0.88	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	144.26	16.55	6.42	1.14	1.00	1.57	0.71	0.71	1.85	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	185.03	18.06	4.46	1.19	0.79	1.69	0.50	0.20	1.09	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	387.31	39.68	7.84	1.94	2.61	1.52	1.77	1.01	1.26	2.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	157.06	11.58	6.51	1.45	0.00	0.72	3.62	1.45	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	181.63	15.00	6.33	2.20	1.51	0.28	0.28	0.69	1.65	0.69
Skin - palm, donor1	10286-104F7	542.59	2.69	5.37	0.00	2.69	0.00	2.69	2.69	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	166.64	2.88	1.87	0.86	1.73	1.01	0.00	0.14	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	202.84	3.27	0.82	0.82	0.00	0.82	0.00	0.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	131.77	2.73	1.82	0.52	0.26	1.17	0.13	0.00	0.52	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	130.53	2.22	1.39	0.97	1.11	1.39	0.00	0.00	0.70	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	168.79	4.92	2.81	0.98	0.70	1.55	0.00	0.00	1.55	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	253.10	4.23	6.98	0.85	0.63	1.69	0.21	0.00	0.85	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	101.33	1.72	0.67	0.67	0.60	0.82	0.00	0.00	0.30	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	216.01	12.34	2.16	2.78	2.47	1.54	0.31	0.00	2.16	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1925.83	85.38	38.46	16.01	9.56	13.78	3.78	1.11	7.56	11.12
Smooth Muscle Cells - Aortic, donor0	11210-116A4	453.80	20.57	13.52	2.35	1.18	0.00	0.59	2.94	2.35	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	645.96	28.29	8.18	2.87	1.10	0.88	0.22	0.22	1.99	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	823.00	54.74	8.27	5.91	3.15	1.97	1.58	0.00	1.18	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	635.05	17.77	14.68	2.32	0.00	1.55	0.00	0.00	1.55	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	156.12	51.04	6.00	1.00	2.00	1.00	1.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	767.06	59.49	13.71	2.66	3.33	4.13	0.13	0.67	2.26	4.26
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	293.69	33.25	6.87	1.99	1.99	3.99	0.66	0.22	2.22	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	252.73	28.29	3.58	4.87	0.77	3.97	0.51	0.51	1.28	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	112.98	5.54	5.21	0.65	0.33	0.65	1.30	0.98	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	208.20	14.47	5.61	1.48	1.18	0.59	0.30	0.00	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	208.85	21.78	2.28	1.71	0.43	1.42	0.28	0.28	0.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	536.99	23.26	10.25	1.14	2.11	2.28	0.33	0.49	0.65	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	251.16	14.31	5.18	1.22	0.91	0.61	0.91	0.30	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	551.60	20.21	12.12	2.53	0.76	2.53	2.02	1.01	1.52	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	146.90	30.60	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	629.42	41.48	14.31	5.72	2.86	4.77	2.38	0.48	7.15	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	207.05	23.15	4.57	0.74	1.03	1.18	0.15	0.29	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	192.21	34.44	8.61	1.94	1.94	2.80	0.65	0.65	1.51	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	156.39	35.06	3.78	1.15	1.15	2.20	0.63	0.21	0.84	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	855.37	56.77	9.44	3.25	1.70	2.32	0.93	0.31	1.39	2.01
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	461.33	64.67	8.62	1.08	1.08	3.23	1.08	0.00	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	433.94	20.32	9.86	3.59	0.30	1.79	0.90	0.30	2.09	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	466.35	84.67	11.95	1.02	1.71	0.68	1.02	0.34	0.68	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	199.62	21.12	11.70	0.79	0.86	0.47	2.04	1.10	0.31	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	375.39	30.90	12.58	4.33	2.52	5.84	0.30	0.40	2.21	12.68
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	677.65	69.40	6.83	4.55	6.83	2.96	0.46	0.46	3.19	4.55
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	669.02	52.53	14.49	11.47	3.62	3.62	1.81	0.60	10.87	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	156.57	57.75	6.89	1.06	0.79	1.06	0.26	0.26	1.32	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	383.10	45.67	10.52	2.93	3.86	3.46	0.27	1.07	1.46	2.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	235.66	50.46	5.38	4.38	4.26	4.88	0.13	0.13	2.75	2.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	292.47	9.89	11.67	1.27	0.51	2.03	0.51	0.25	1.01	3.55
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	734.42	22.16	10.86	3.17	1.36	3.47	2.11	0.75	1.51	2.86
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	341.33	15.75	11.25	6.00	3.75	0.75	1.50	0.00	3.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	156.36	15.51	6.46	9.05	0.00	18.09	2.58	0.00	18.09	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	479.95	36.28	17.67	3.26	1.40	0.47	0.47	1.40	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	531.64	56.55	8.58	4.04	3.53	3.53	1.01	0.00	1.51	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	423.71	62.37	7.52	7.52	3.13	4.70	0.31	0.00	5.95	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	251.63	14.16	7.96	0.59	2.06	0.88	0.59	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	269.25	29.16	8.16	0.25	0.50	0.42	0.58	0.42	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	273.76	12.61	8.41	0.47	0.93	0.00	0.00	0.93	2.34	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	664.90	47.06	8.78	3.45	1.73	3.02	0.00	0.29	1.30	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	410.73	37.22	8.67	2.55	2.04	2.55	0.25	0.25	3.31	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	380.20	27.64	8.84	3.57	1.69	1.88	0.56	0.19	2.44	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	345.87	48.63	10.90	0.70	1.54	0.56	1.40	0.42	0.70	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	574.87	28.57	9.47	0.92	1.59	0.50	0.92	0.67	0.50	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	258.57	16.67	11.43	0.00	0.00	0.95	0.00	0.00	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	528.22	39.64	8.07	1.96	2.45	3.43	0.73	0.00	1.71	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	942.79	120.86	12.59	10.83	10.83	8.40	0.66	0.22	3.76	7.29
Smooth Muscle Cells - Uterine, donor3	11466-119B8	336.76	16.38	9.36	0.88	0.59	0.88	0.29	0.29	2.34	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	217.88	12.63	7.58	1.55	1.17	3.69	0.19	0.39	0.58	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	483.42	31.21	6.35	5.55	3.70	5.02	0.53	0.00	3.70	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	401.70	24.55	5.58	3.72	5.21	4.46	0.00	0.00	4.46	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	413.24	30.18	9.34	4.31	3.95	6.11	0.72	0.36	3.95	3.23
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	185.95	9.08	1.70	1.14	0.28	0.00	0.28	0.57	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	437.59	28.75	5.51	2.36	3.94	4.73	0.39	0.00	1.58	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	301.44	44.19	8.38	5.84	2.03	5.08	0.25	0.00	2.79	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	221.22	19.17	9.98	2.80	1.20	2.80	0.40	0.00	0.40	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	201.48	20.90	2.51	2.93	0.84	2.51	0.42	0.42	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	139.80	6.42	4.58	0.92	0.46	1.38	0.92	0.46	0.92	0.92
Synoviocyte, donor1	11291-117A4	993.26	33.16	16.50	2.52	4.71	5.39	1.35	0.34	2.36	10.77
Synoviocyte, donor2	11368-117I9	210.03	15.59	12.57	2.51	1.51	2.68	0.00	0.17	1.84	2.01
Synoviocyte, donor3	11440-118H9	201.74	21.22	9.83	2.46	2.23	3.57	0.22	0.00	2.23	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	390.92	32.16	13.58	1.07	0.36	0.36	1.43	1.79	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	138.74	11.89	1.98	0.00	0.00	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	255.40	19.91	10.88	0.69	0.69	0.46	0.69	0.93	0.69	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	123.23	1.79	3.51	0.79	0.29	0.50	0.29	0.00	0.43	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	114.81	2.32	3.48	1.16	0.00	0.39	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	79.60	4.01	2.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	207.17	23.87	3.69	1.48	1.85	1.97	0.25	0.25	0.49	0.00
Urethra, donor2	10319-105A4	543.13	17.98	8.99	10.79	0.00	0.00	5.40	0.00	5.40	1.80
Urothelial Cells, donor1	11520-119H8	403.27	7.17	3.45	1.06	2.92	1.06	0.00	0.00	1.06	0.80
Urothelial Cells, donor2	11600-120H7	173.44	1.20	1.60	0.80	1.20	0.00	0.00	0.00	2.00	0.00
Urothelial Cells, donor3	11681-122H7	200.33	1.60	2.98	1.83	0.69	0.92	0.00	0.23	0.69	0.69
Urothelial cells, donor0	11216-116B1	337.02	4.46	4.46	2.01	1.56	0.45	0.00	0.00	1.56	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	1546.44	263.38	22.24	7.12	8.01	4.45	0.00	0.00	5.34	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	1854.21	193.00	27.16	5.72	7.15	1.43	0.00	0.00	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	907.67	138.96	4.11	6.16	8.21	5.48	0.00	0.00	4.11	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	841.91	135.67	12.40	3.79	2.75	2.75	0.34	0.00	1.03	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	945.91	151.07	8.13	2.32	3.49	1.16	0.00	0.00	0.00	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	1613.92	284.26	16.66	4.16	11.45	1.04	0.00	0.00	2.08	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	1384.95	186.31	22.03	6.42	4.59	2.75	0.00	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	906.51	146.98	4.56	8.22	10.95	5.48	0.00	0.00	3.65	4.56
Wilms' tumor cell line:G-401	10809-111A8	107.57	41.45	8.88	0.99	1.36	1.36	4.19	4.32	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	13.20	11.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	178.20	5.31	1.68	0.56	0.56	1.12	0.00	0.00	0.84	0.28
achilles tendon, donor2	10292-104G4	417.44	24.80	2.07	4.13	2.07	0.00	0.00	0.00	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	18.57	104.71	0.00	0.70	0.23	0.23	0.00	0.00	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	24.22	58.78	2.72	0.27	0.27	0.82	0.27	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	77.30	164.43	2.81	2.25	1.97	1.41	0.00	0.00	1.41	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.32	140.63	0.21	0.63	0.42	0.42	0.00	0.00	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.34	347.61	0.00	4.08	1.36	2.45	0.00	0.00	1.63	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	42.74	143.65	0.00	2.20	0.88	0.88	0.00	0.00	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	250.73	0.00	2.45	2.04	1.23	0.00	0.00	2.04	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.51	205.80	0.39	0.39	1.16	0.78	0.00	0.00	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.05	187.31	0.00	2.39	1.66	1.29	0.00	0.00	0.74	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	117.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	36.02	161.97	0.00	0.70	1.16	1.39	0.00	0.00	0.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	43.75	294.37	1.04	1.29	1.29	2.85	0.26	0.00	2.07	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	22.50	234.38	0.00	2.92	1.75	2.34	0.00	0.00	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	49.26	261.66	0.93	1.39	0.46	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	178.48	315.02	0.82	3.70	1.23	1.65	0.00	0.00	2.06	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	26.40	182.02	0.31	0.92	5.22	1.53	0.00	0.00	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	50.78	218.05	0.43	1.28	1.28	1.71	0.00	0.00	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.09	245.36	0.61	0.30	0.91	0.91	0.00	0.00	1.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	72.21	304.97	1.20	1.93	0.96	0.48	0.00	0.00	0.24	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.70	139.43	0.00	1.78	1.56	0.89	0.00	0.00	1.11	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.67	44.36	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	189.54	0.00	0.00	0.00	3.72	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	77.59	220.35	0.00	0.75	1.51	2.26	0.00	0.00	1.13	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.12	214.14	0.00	1.31	1.74	0.87	0.00	0.00	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	552.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.36	4.95	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	467.68	12.10	6.05	2.48	1.55	5.74	0.16	0.47	0.93	1.55
adipose, donor1	10184-103D4	99.10	30.49	3.52	4.10	3.52	11.73	5.86	4.69	1.17	3.52
adipose, donor2	10185-103D5	74.21	12.17	4.46	1.62	1.62	2.43	28.79	27.98	1.22	1.22
adipose, donor3	10186-103D6	52.82	16.34	8.44	2.45	0.54	2.45	12.53	12.53	1.09	1.63
adipose, donor4	10187-103D7	55.47	19.07	4.33	0.87	0.87	6.07	2.60	7.80	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	83.80	89.17	0.00	0.47	0.47	0.32	0.00	0.00	0.79	0.63
adrenal gland, adult, pool1	10081-102A9	47.29	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.28	0.40	0.40	0.13	0.53	0.00	0.00	0.00	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	427.69	101.12	14.29	2.50	3.22	3.93	0.00	0.36	2.86	2.14
amniotic membrane cells, donor1	12235-129G3	606.52	12.52	5.33	4.87	1.62	3.01	0.00	0.00	2.32	1.39
amniotic membrane cells, donor2	12236-129G4	101.09	17.58	2.37	0.00	0.00	1.01	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	193.85	3.83	7.66	1.47	1.47	0.59	0.00	0.00	0.88	0.00
amygdala - adult, donor10196	10167-103B5	77.08	4.74	79.45	2.37	1.19	2.37	17.79	23.72	0.00	1.19
amygdala, adult, donor10252	10151-102I7	68.94	14.60	43.59	1.01	0.20	0.41	7.91	8.31	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	151.70	56.81	34.54	0.65	1.61	1.29	15.49	18.72	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	315.01	17.70	10.82	1.91	0.89	2.04	0.89	0.64	0.89	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2.65	60.45	0.00	0.66	0.22	0.44	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	2.00	47.43	0.00	0.00	0.33	0.33	0.00	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	857.69	18.04	24.52	4.31	4.12	5.30	0.98	0.59	3.73	2.55
appendix, adult	10189-103D9	352.02	31.05	10.87	3.10	1.94	4.27	0.78	0.00	1.55	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.99	27.17	9.29	0.69	0.00	0.34	0.34	0.00	0.34	0.00
artery, adult	10190-103E1	289.40	10.87	10.87	1.36	2.72	5.43	0.00	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	67.94	32.45	4.06	0.14	0.43	1.01	0.43	0.87	0.00	0.14
b cell line:RPMI1788	10427-106D4	29.00	9.81	0.45	0.30	0.30	0.00	0.00	0.00	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	853.98	32.74	12.21	5.83	2.77	3.88	0.28	0.83	3.88	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	241.83	19.65	4.47	0.50	1.79	1.39	0.60	0.10	0.50	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	24.27	14.90	0.33	0.33	0.33	0.00	0.00	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	91.72	199.09	3.91	1.68	1.12	0.56	0.00	0.00	1.12	1.12
bladder, adult, pool1	10011-101C2	826.00	16.19	13.15	3.91	1.74	3.26	0.65	0.00	3.69	3.69
blood, adult, pool1	10053-101G8	239.18	73.08	2.21	0.00	2.21	6.64	0.00	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	584.88	9.42	10.28	0.86	0.00	0.86	0.00	0.00	1.71	0.00
bone marrow, adult	10192-103E3	121.47	31.72	2.02	0.67	0.67	1.35	3.37	0.67	0.00	2.02
brain, adult, donor1	10084-102B3	48.18	8.20	49.20	2.05	1.03	0.00	13.33	3.08	0.00	1.03
brain, adult, pool1	10012-101C3	57.57	6.68	55.35	0.56	0.45	1.00	8.13	11.47	1.11	0.56
brain, fetal, pool1	10085-102B4	61.44	0.00	29.39	0.00	0.00	0.00	8.01	18.70	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	126.53	58.47	0.00	0.66	0.00	0.00	0.00	0.00	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	256.14	82.38	0.00	0.25	1.25	0.87	0.00	0.00	0.25	0.25
breast, adult, donor1	10080-102A8	312.52	19.57	6.31	7.58	0.00	3.79	0.63	0.00	4.42	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	49.67	25.41	0.76	0.64	0.38	0.25	0.00	0.00	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	367.35	132.96	12.68	1.24	3.71	1.86	0.62	0.00	1.55	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	341.18	24.86	16.58	3.68	3.91	2.30	0.46	0.69	1.84	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.23	19.85	6.05	0.24	0.24	0.24	0.00	0.24	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	172.38	24.50	8.75	0.33	0.55	1.09	0.22	0.00	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	107.11	9.82	0.00	0.95	0.00	0.00	0.00	0.00	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.00	5.59	0.53	0.00	0.00	0.27	0.27	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	82.90	10.36	41.45	0.00	0.00	2.30	11.51	12.66	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	33.80	10.21	24.93	0.84	0.17	0.00	8.03	9.87	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	31.33	0.76	39.74	0.00	0.00	0.76	13.75	20.63	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	73.25	19.78	10.25	1.10	0.37	0.37	16.48	16.48	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	46.61	2.91	52.44	2.91	0.00	2.91	17.48	23.31	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	31.81	6.41	49.75	1.28	0.64	0.64	10.46	13.66	1.07	0.21
cerebellum, adult, pool1	10083-102B2	11.38	2.41	33.11	0.34	0.34	0.69	6.90	11.73	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	48.16	5.81	19.10	1.66	0.00	0.83	1.66	4.15	0.00	0.00
cerebral meninges, adult	10188-103D8	76.15	5.55	27.23	0.76	0.50	1.26	7.82	8.82	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	165.91	10.96	5.85	2.19	2.19	2.19	0.73	0.73	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.77	10.35	1.73	0.43	1.01	0.29	1.01	0.14	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	351.82	3.65	2.82	1.82	1.33	1.49	0.00	0.00	0.83	1.33
cervix, adult, pool1	10013-101C4	888.64	18.79	21.84	5.04	1.68	5.35	5.77	4.72	2.73	2.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	267.67	20.90	5.99	1.95	1.67	1.81	0.00	0.42	1.39	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	224.68	7.84	10.45	0.00	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	156.96	51.95	1.12	2.11	1.24	2.36	0.00	0.00	0.87	2.73
choriocarcinoma cell line:SCH	10785-110H2	309.26	6.65	1.48	1.36	1.36	1.97	0.12	0.25	0.74	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	473.17	27.75	5.93	1.66	1.42	3.32	0.00	0.00	1.19	1.90
chorionic membrane cells, donor1	12238-129G6	870.43	20.23	5.70	5.13	4.27	6.55	0.57	0.28	1.71	1.42
chorionic membrane cells, donor2	12239-129G7	377.94	26.65	7.46	4.18	2.19	5.27	0.40	0.30	1.39	3.88
chorionic membrane cells, donor3	12240-129G8	908.30	39.01	6.59	6.59	12.09	13.74	1.10	0.00	6.04	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	36.35	0.00	0.00	0.00	0.00	0.00	0.00	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	109.30	216.88	0.58	1.34	0.77	1.73	0.00	0.00	1.15	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	54.49	299.25	0.63	1.06	1.06	2.32	0.00	0.00	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.46	116.59	0.00	0.77	0.77	0.51	0.00	0.00	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	21.77	144.64	0.48	0.73	0.73	0.48	0.00	0.00	0.73	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	29.12	147.82	0.20	0.41	1.02	1.22	0.00	0.00	1.43	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	8.83	60.07	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	98.78	443.32	0.78	1.04	3.13	0.78	0.00	0.00	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	249.61	43.20	16.23	5.71	3.20	2.97	10.29	8.46	1.83	2.97
clear cell carcinoma cell line:TEN	10636-108I6	415.03	44.94	4.68	3.12	0.69	0.87	1.04	0.35	1.74	1.21
colon carcinoma cell line:CACO-2	10513-107D9	226.61	53.27	0.18	0.73	1.28	0.73	0.00	0.00	0.55	0.55
colon carcinoma cell line:COLO-320	10420-106C6	1.90	4.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	322.50	60.69	9.52	1.19	2.38	3.57	2.38	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	333.59	30.08	7.64	1.76	1.18	3.17	0.59	0.24	0.59	3.17
colon, fetal, donor1	10070-101I7	440.01	51.29	17.30	4.94	3.09	6.18	6.18	6.18	4.94	4.94
common myeloid progenitor CMP, donor1	12130-128D6	426.27	169.59	0.00	0.00	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	250.37	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	177.62	28.05	1.27	2.55	0.42	0.42	0.42	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	92.22	68.22	2.72	0.91	0.15	0.15	0.00	0.30	0.15	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	83.34	77.42	2.82	0.42	0.56	0.56	0.00	0.00	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	222.89	15.70	59.37	0.33	0.66	0.44	3.65	3.43	0.55	0.44
cruciate ligament, donor2	10295-104G7	526.00	12.97	8.10	2.43	0.81	4.05	1.62	0.00	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	574.64	15.25	14.45	3.21	2.41	4.82	4.82	1.61	6.42	3.21
diencephalon, adult	10193-103E4	57.84	6.96	24.00	0.24	0.00	0.72	4.08	3.36	1.20	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	265.67	38.21	6.15	0.77	1.03	0.51	0.00	0.00	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	184.63	21.42	1.44	0.48	0.96	0.48	0.96	0.24	0.24	0.96
ductus deferens, adult	10196-103E7	252.16	51.83	3.99	1.50	0.50	0.50	1.50	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	276.52	37.45	15.84	2.88	0.00	7.20	1.44	4.32	7.20	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	378.12	52.97	15.45	7.36	2.21	2.21	5.89	5.15	5.15	3.68
dura mater, adult, donor1	10041-101F5	232.15	31.80	11.07	1.49	0.17	0.41	0.74	0.91	0.50	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.99	7.33	0.22	0.44	0.00	0.22	0.00	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.92	16.91	0.29	0.14	0.00	0.43	0.00	0.00	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	156.62	26.51	11.10	0.00	1.23	0.62	3.70	2.47	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	240.65	20.58	10.59	2.12	0.61	0.91	6.66	4.54	0.91	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	176.91	39.52	11.11	1.23	0.31	0.93	3.70	1.85	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	186.51	32.84	11.82	1.31	0.00	0.00	2.63	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	109.27	183.02	0.34	0.34	1.34	0.34	0.34	1.01	1.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	144.08	30.45	19.21	1.63	1.63	1.09	4.17	3.26	1.27	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	421.97	22.51	2.41	4.18	4.18	4.18	0.00	0.16	3.86	1.45
epidermoid carcinoma cell line:A431	10426-106D3	200.75	1.78	1.45	0.56	0.44	0.67	0.22	0.00	0.22	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.88	0.00	0.00	0.00	0.00	0.11	0.00	0.00	0.00	0.00
epididymis, adult	10197-103E8	362.53	29.09	7.54	6.70	0.63	8.79	1.05	0.63	2.09	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	329.63	69.19	11.89	0.71	4.08	2.13	3.55	3.37	1.77	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	81.40	83.76	3.15	0.00	0.39	0.79	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.95	2.36	1.31	0.13	0.00	0.00	0.00	0.00	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.04	2.26	1.57	0.30	0.10	0.10	0.39	0.20	0.30	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	16.80	1.34	1.34	0.22	0.11	0.11	0.00	0.00	0.22	0.00
esophagus, adult, pool1	10015-101C6	447.01	6.90	9.66	2.44	1.81	3.19	0.11	0.11	1.59	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	319.10	58.74	7.51	1.00	1.13	1.25	2.50	2.76	0.50	1.13
eye - muscle inferior rectus, donor1	10272-104E2	130.39	2.41	21.73	0.00	0.00	0.00	0.00	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	324.05	23.15	2.10	4.21	0.00	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	184.54	5.95	4.46	1.49	0.00	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	245.35	19.49	8.03	1.15	0.00	1.15	0.00	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	269.62	30.61	0.00	5.83	0.00	4.37	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	191.95	24.15	14.75	1.27	2.03	1.27	5.34	5.59	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	131.56	17.82	10.77	1.41	1.15	0.64	0.26	0.77	1.03	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	67.66	28.49	0.24	0.47	0.47	0.71	0.00	0.00	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	78.25	6.76	81.06	0.66	0.38	0.09	11.73	18.20	0.38	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	153.43	30.63	1.20	0.90	0.90	1.50	0.30	0.00	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	336.85	31.27	11.25	0.73	0.82	0.91	1.37	1.37	0.64	0.55
gall bladder, adult	10198-103E9	310.96	32.35	9.66	4.59	1.45	5.31	0.97	0.24	2.41	1.45
gamma delta positive T cells, donor1	11937-126A2	269.50	13.96	10.20	2.68	0.00	0.54	0.00	0.00	2.15	2.15
gamma delta positive T cells, donor2	11938-126A3	141.18	14.19	5.60	0.37	0.37	0.37	0.00	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	947.94	40.34	2.53	11.62	8.24	6.97	4.65	0.84	9.29	3.38
gastric adenocarcinoma cell line:MKN45	10612-108F9	86.07	33.65	3.48	0.58	0.77	0.97	0.97	0.39	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	207.24	133.46	10.49	0.82	0.98	0.66	1.64	2.95	0.49	0.66
gastric cancer cell line:GSS	10560-108A2	214.16	59.49	21.05	0.92	0.00	0.92	5.49	11.90	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	151.24	47.52	12.79	3.43	1.37	0.91	5.71	4.34	1.37	1.37
giant cell carcinoma cell line:LU65	10487-107B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	183.49	34.99	4.06	0.84	0.98	1.12	0.98	0.84	0.70	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	22.45	13.47	0.25	0.25	0.25	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	303.99	61.85	24.49	1.27	0.95	0.63	2.85	3.06	0.95	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	330.31	66.85	26.54	0.56	0.70	1.26	4.35	1.54	0.28	0.28
glioblastoma cell line:T98G	10485-107A8	104.97	46.47	9.38	0.88	0.77	0.11	0.55	0.44	0.22	0.33
glioma cell line:GI-1	10413-106B8	125.06	41.59	7.03	1.76	0.88	0.88	0.29	0.29	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	65.60	5.83	31.34	2.92	0.00	0.00	5.83	9.48	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	90.80	22.46	18.31	0.73	0.49	0.73	0.73	1.46	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	42.45	2.74	19.17	0.00	0.00	1.37	2.74	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	40.50	7.46	9.59	0.53	0.00	0.53	7.99	3.73	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	548.16	159.06	9.79	0.00	0.00	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	437.14	131.14	0.00	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	261.33	99.31	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	328.64	13.76	9.60	1.60	0.64	1.60	1.28	0.64	2.24	0.96
hIPS +CCl2, biol_rep1	14383-156B9	181.35	68.87	7.80	0.46	0.00	0.92	3.67	3.21	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	170.56	61.73	13.26	0.46	0.91	1.37	1.83	6.86	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	203.53	67.63	5.15	0.64	1.29	0.64	2.58	2.58	0.00	1.93
hIPS, biol_rep1	14380-156B6	158.10	45.99	4.31	0.00	2.87	1.44	5.75	2.87	0.00	1.44
hIPS, biol_rep2	14381-156B7	98.76	43.90	4.80	1.37	1.37	0.00	3.43	7.54	0.69	1.37
hIPS, biol_rep3	14382-156B8	48.55	8.83	29.79	0.00	1.10	0.00	9.93	13.24	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	3.74	1.15	1.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	632.62	13.75	16.74	2.99	2.99	2.69	1.49	0.30	4.19	1.79
heart - pulmonic valve, adult	10206-103F8	646.89	17.00	15.95	1.05	2.09	4.18	1.31	0.78	2.88	3.66
heart - tricuspid valve, adult	10207-103F9	184.01	9.16	0.83	0.00	0.00	1.67	0.83	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	304.25	20.81	14.08	2.86	1.84	2.04	0.41	0.20	2.24	1.43
heart, adult, diseased, donor1	10051-101G6	460.75	17.46	29.38	2.55	2.55	2.98	0.85	0.43	2.13	0.85
heart, adult, pool1	10016-101C7	209.51	11.04	6.21	0.00	0.69	0.92	0.00	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	837.46	50.21	31.11	1.54	1.03	1.23	5.03	5.34	1.64	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1290.86	41.34	17.89	2.78	5.86	5.86	0.93	0.93	4.32	3.39
hepatoblastoma cell line:HuH-6	10633-108I3	435.24	17.84	7.14	0.00	0.00	0.00	2.38	4.76	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	178.89	40.77	6.74	1.44	1.10	1.33	14.47	7.18	0.99	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	157.79	41.51	5.83	1.34	2.31	0.97	13.35	5.10	1.21	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	194.73	46.28	7.07	1.82	1.72	0.81	18.09	7.28	1.72	0.61
hepatoma cell line:Li-7	10484-107A7	102.65	59.50	0.00	0.67	0.67	0.78	0.00	0.00	0.78	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	56.78	10.41	43.53	0.00	0.95	0.00	5.68	5.68	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	74.29	10.41	27.15	0.41	0.20	0.41	6.12	6.33	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	62.74	3.49	64.73	0.50	1.00	0.50	17.43	10.46	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.73	10.22	23.97	0.70	0.00	0.00	18.33	14.10	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	142.82	26.24	7.93	1.83	0.61	4.27	3.05	7.32	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	100.14	17.87	3.93	1.18	1.57	1.57	6.68	2.95	0.59	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	94.20	18.03	5.33	0.51	0.25	1.78	5.33	5.33	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	93.60	27.63	6.20	2.26	1.13	10.71	9.02	13.53	2.26	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	91.15	49.32	5.94	4.65	5.68	11.10	8.52	19.11	2.58	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	95.66	41.38	6.07	3.04	2.28	13.67	12.91	14.05	0.38	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	54.30	22.19	8.76	2.63	0.88	7.59	9.34	12.85	1.46	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.43	21.33	7.76	3.23	1.72	5.39	11.20	18.31	0.86	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	76.74	17.93	2.92	2.50	1.25	5.00	5.00	5.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	53.52	11.84	3.32	0.71	0.24	0.95	2.84	2.60	0.24	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	70.72	21.54	4.34	0.64	0.96	3.70	6.11	4.50	0.64	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	10.77	4.04	1.35	0.00	1.35	5.39	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	79.96	26.76	6.42	1.56	1.10	2.66	4.69	6.10	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	96.29	38.32	6.88	3.93	0.49	2.95	4.91	6.88	2.46	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	134.40	32.29	4.36	3.49	0.87	5.24	8.73	6.11	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	180.03	54.60	14.13	6.68	3.44	15.65	13.94	24.82	1.53	4.77
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	177.05	53.64	10.90	3.92	2.18	10.47	10.47	15.70	1.31	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	178.91	62.97	16.99	3.00	2.00	12.49	6.50	16.49	2.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	101.73	15.26	6.22	3.39	2.83	8.10	33.72	37.30	1.70	3.20
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	108.68	14.55	9.55	4.09	4.09	7.73	35.47	42.74	1.36	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	87.39	13.16	8.46	3.45	4.39	5.95	27.88	35.40	0.63	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	81.32	20.58	10.45	2.45	1.80	3.59	15.02	14.70	1.14	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	82.45	20.32	11.32	2.90	1.74	6.10	17.71	16.26	2.03	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	84.00	16.44	8.97	4.18	0.60	3.89	18.53	17.94	1.20	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	106.60	34.36	8.50	1.66	0.74	3.14	7.02	7.94	0.74	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	112.97	24.25	7.70	2.28	2.00	2.85	6.56	7.70	1.43	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	146.58	51.45	7.76	0.82	2.86	4.08	7.35	6.94	0.00	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	196.46	69.01	10.91	4.93	3.87	14.08	9.15	14.08	1.76	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	174.52	55.43	7.60	5.70	3.48	12.04	11.40	10.77	1.27	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	187.62	64.76	11.50	4.54	5.14	8.47	9.38	14.53	2.72	6.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	84.29	22.75	10.86	1.55	2.07	6.72	12.93	20.17	0.52	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	86.34	24.57	8.63	2.66	3.32	9.96	17.27	24.57	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.61	15.65	5.13	0.51	0.77	1.54	6.16	10.52	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	87.18	26.59	7.16	2.56	1.79	3.58	8.44	7.67	1.79	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	71.94	18.93	8.33	3.03	2.27	0.00	16.66	20.45	0.76	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	115.27	24.87	3.70	3.36	2.02	4.70	9.75	7.06	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	92.74	44.68	9.42	2.17	1.93	2.90	7.97	7.25	0.72	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.61	39.66	12.03	1.78	1.78	3.12	4.01	5.79	1.78	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	103.42	39.02	12.68	1.95	1.95	4.39	7.80	3.90	1.95	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	158.00	67.85	7.03	4.58	4.58	7.95	13.14	17.11	2.14	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	123.62	71.57	0.00	3.25	16.27	29.28	0.00	0.00	6.51	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	217.43	70.49	12.24	6.29	4.30	16.88	10.92	18.53	1.99	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	70.05	21.89	8.21	3.28	2.74	3.83	18.06	20.80	0.00	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	61.88	20.99	5.79	2.53	1.81	2.53	17.37	21.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	59.07	20.28	5.34	3.20	1.07	3.56	16.01	20.28	0.36	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	72.80	14.32	4.77	0.00	1.19	2.39	7.16	21.48	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	80.85	19.23	11.78	2.30	0.54	4.88	14.76	14.90	0.95	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	54.42	14.82	5.93	0.54	0.81	2.16	9.43	9.16	0.54	0.54
immature langerhans cells, donor1	11904-125F5	879.96	59.08	3.39	3.39	1.45	3.63	0.00	0.00	2.18	1.21
immature langerhans cells, donor2	11905-125F6	794.51	48.32	3.17	2.38	3.96	2.38	0.00	0.00	3.17	5.54
insula, adult, pool1	10039-101F3	106.18	7.76	90.19	0.47	0.28	0.38	22.05	24.42	0.38	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	136.37	18.42	2.90	0.80	0.90	0.70	0.10	0.10	0.40	0.40
kidney, fetal, pool1	10045-101F9	325.53	40.32	18.89	0.92	0.78	0.64	7.71	6.72	0.28	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	328.92	35.36	9.94	1.28	1.28	0.71	3.83	2.41	0.57	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	52.81	2.90	2.21	1.38	0.28	0.55	0.69	0.28	0.69	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	142.95	0.73	2.20	0.37	1.10	0.73	0.73	0.18	0.73	0.18
left atrium, adult, donor1	10079-102A7	249.54	10.90	15.80	2.18	0.54	3.27	1.09	0.00	2.72	1.09
left ventricle, adult, donor1	10078-102A6	314.52	10.11	10.11	2.53	1.52	7.08	0.00	0.51	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	147.48	60.19	2.46	0.82	0.82	1.09	0.00	0.27	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	166.69	20.48	3.23	4.31	2.51	1.80	0.36	0.00	2.87	2.16
leiomyoma cell line:15242A	10570-108B3	313.59	58.15	3.26	7.61	2.72	5.98	0.00	0.00	1.63	2.72
leiomyoma cell line:15425	10571-108B4	232.37	24.77	7.53	3.40	3.16	2.43	0.97	0.24	3.16	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	165.08	6.35	0.00	0.00	0.00	6.35	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	64.82	43.91	2.09	0.00	0.00	0.00	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	166.82	207.66	0.00	1.65	1.53	1.06	0.00	0.00	1.06	0.59
liposarcoma cell line:KMLS-1	10782-110G8	165.90	82.17	7.65	1.72	1.56	1.41	0.78	0.47	1.09	0.62
liposarcoma cell line:SW 872	10726-110A6	231.01	31.80	0.00	0.97	1.10	0.85	0.00	0.00	0.73	0.49
liver, adult, pool1	10018-101C9	61.58	78.11	1.46	1.62	0.81	1.78	0.00	0.00	0.49	0.16
liver, fetal, pool1	10086-102B5	65.85	26.34	0.00	0.94	0.00	0.94	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	76.12	3.50	32.81	0.29	0.15	0.15	8.17	4.08	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	59.24	9.97	19.56	0.74	0.55	0.55	6.64	4.24	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	38.09	5.08	24.83	0.85	0.85	0.85	9.31	6.49	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	147.64	27.34	18.93	1.26	0.42	1.26	8.83	12.20	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	207.73	31.69	2.77	0.97	0.55	0.42	1.80	1.11	0.55	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	464.66	113.75	42.05	0.00	0.00	0.00	0.69	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	259.41	103.34	2.90	1.19	0.53	1.71	0.00	0.00	0.26	0.66
lung, adult, pool1	10019-101D1	467.19	22.56	8.39	2.60	1.65	2.95	0.12	0.12	0.71	1.30
lung, fetal, donor1	10068-101I5	1653.94	73.92	49.66	7.14	2.85	4.28	11.70	4.00	5.14	4.00
lung, right lower lobe, adult, donor1	10075-102A3	336.33	28.41	10.08	5.04	0.92	10.08	0.46	0.00	4.12	3.21
lymph node, adult, donor1	10077-102A5	146.27	47.81	6.15	2.84	1.89	3.79	0.47	0.00	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	13.15	5.04	1.53	0.22	0.00	0.22	0.00	0.00	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	265.89	8.49	5.10	0.00	0.85	0.00	0.00	0.00	0.85	0.85
mature adipocyte, donor1	12231-129F8	277.49	10.21	3.11	0.89	0.00	0.00	0.00	0.44	0.44	0.44
mature adipocyte, donor2	12232-129F9	475.24	15.36	7.26	1.66	1.66	2.70	0.21	0.00	0.83	0.21
mature adipocyte, donor3	12233-129G1	592.89	15.65	4.98	1.42	0.95	3.32	0.00	0.00	0.71	1.90
mature adipocyte, donor4	12234-129G2	460.89	26.32	2.63	2.11	1.05	1.32	0.26	0.00	0.53	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.46	42.41	9.77	0.95	0.24	0.48	1.19	1.43	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	49.63	6.77	71.07	0.00	1.13	1.13	10.15	11.28	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	73.01	10.48	54.80	0.55	0.18	0.92	6.99	6.99	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	33.99	3.18	62.27	0.32	0.00	0.00	11.12	12.07	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	86.15	23.46	13.65	0.85	0.43	0.85	6.40	9.81	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	62.61	17.21	72.06	2.36	1.18	1.18	12.66	15.36	1.86	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	90.20	11.88	48.39	0.42	0.64	0.21	6.37	5.31	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	67.42	1.93	40.45	1.93	1.93	0.00	5.78	7.71	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	84.71	23.33	35.18	0.36	0.72	0.00	15.08	19.38	1.44	0.00
medulla oblongata - adult, donor10196	10174-103C3	101.24	13.63	19.47	0.00	0.00	1.30	5.84	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	72.29	17.18	18.58	0.31	0.46	0.77	3.56	2.63	0.62	0.00
medulla oblongata, adult, pool1	10038-101F2	119.34	10.53	36.57	0.16	0.08	0.41	6.86	5.55	0.41	0.16
medulla oblongata, newborn, donor10223	10361-105F1	94.09	11.46	15.97	1.04	0.00	0.35	11.11	5.90	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	3.54	6.64	0.00	0.44	0.44	0.00	0.00	0.00	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	43.90	12.11	6.11	0.12	0.37	0.24	1.59	0.24	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	89.55	5.75	4.17	1.15	0.43	0.72	0.14	0.00	0.14	0.72
melanoma cell line:G-361	10465-106H6	59.45	4.34	0.00	0.27	0.54	0.54	0.00	0.00	0.27	1.09
meningioma cell line:HKBMM	10691-109F7	160.28	8.14	4.16	1.81	1.27	2.53	0.90	0.00	2.17	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	31.37	1.04	2.85	0.26	0.00	0.00	3.37	2.59	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	262.37	25.16	10.43	2.45	0.92	1.23	0.77	0.15	1.53	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	151.24	16.36	4.54	0.73	0.55	1.27	0.00	0.73	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	214.92	14.91	6.21	2.90	2.07	1.66	0.00	0.00	2.90	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	116.73	4.92	5.48	1.97	0.70	0.42	0.14	0.00	0.98	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	108.42	10.78	6.93	0.39	0.58	0.39	0.39	0.00	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	166.58	23.60	6.25	2.08	2.78	0.00	0.00	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	187.08	25.75	6.18	2.40	1.20	1.72	0.17	0.00	1.20	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	213.93	16.45	8.40	1.84	1.27	2.07	0.46	0.00	1.38	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	264.61	18.04	8.62	1.99	1.59	2.65	0.66	0.27	1.06	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	350.29	14.18	8.78	2.57	3.11	1.89	0.14	0.41	1.76	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	389.09	26.46	6.69	1.99	3.27	2.99	0.71	0.57	1.28	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	197.61	24.04	7.58	2.31	0.66	1.65	0.33	0.66	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	311.06	23.25	8.86	1.80	0.97	1.80	0.83	1.11	1.11	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	425.53	16.41	5.24	2.44	3.49	1.05	0.00	0.70	1.75	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	269.09	12.66	7.96	2.86	1.22	2.04	0.00	0.20	1.63	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	446.44	23.36	9.71	5.39	2.16	2.88	1.44	0.72	3.59	4.31
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	369.73	14.90	10.66	1.76	2.69	2.17	0.62	0.72	1.14	1.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	499.07	47.88	7.07	5.93	3.19	6.61	0.00	0.68	5.02	2.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	341.52	23.08	4.20	3.78	3.36	3.36	0.42	0.00	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	269.14	13.60	10.16	1.94	2.39	1.79	0.15	0.15	0.90	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	307.67	18.12	6.13	3.15	1.75	2.63	0.96	0.35	1.93	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	406.82	15.09	15.09	2.58	1.10	1.84	0.74	0.37	3.31	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	520.52	39.78	6.58	7.15	4.01	4.58	1.72	0.00	3.43	3.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	95.99	13.05	5.89	1.26	0.84	3.37	0.00	0.00	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	285.42	15.53	5.48	0.91	0.46	4.57	0.00	0.00	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	334.05	21.74	4.60	2.30	2.30	3.58	0.00	0.00	1.53	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	360.18	16.75	6.02	2.62	2.36	2.62	0.26	0.26	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	353.99	14.79	4.01	2.46	3.08	2.77	0.31	0.31	1.54	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	329.73	21.18	5.18	4.24	1.88	2.35	0.24	0.00	1.65	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	346.24	18.95	3.38	3.05	3.72	3.38	0.34	0.34	1.69	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	313.98	14.54	3.54	3.54	0.39	1.96	0.39	0.39	1.18	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	309.08	15.29	2.32	2.78	1.85	2.78	0.46	0.93	2.32	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	357.35	25.67	6.06	3.17	1.15	1.44	0.29	1.15	2.88	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	316.13	17.40	5.80	1.12	2.01	1.12	0.45	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	338.17	19.47	5.77	0.96	2.16	2.40	0.24	0.24	1.20	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	435.60	21.27	4.40	0.73	0.73	0.73	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	283.29	15.44	4.03	3.36	1.01	1.68	0.00	0.00	1.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	346.74	13.51	2.87	0.41	3.68	1.64	0.82	1.23	2.87	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	315.73	15.46	4.30	0.86	3.01	2.58	0.86	0.00	0.86	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	333.60	8.20	2.73	5.47	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	335.72	25.82	0.00	5.16	0.00	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	238.07	15.59	3.25	5.85	1.62	0.65	0.00	0.00	1.30	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	286.63	32.01	4.36	7.27	2.91	0.00	1.45	0.00	1.45	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	340.10	19.72	5.33	5.86	0.53	2.67	2.13	0.00	2.67	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	278.04	16.36	7.36	4.91	2.45	0.82	1.64	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	273.27	20.99	3.89	3.50	0.78	3.11	0.78	0.00	1.55	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	274.93	18.89	2.10	6.30	2.10	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	273.20	24.84	1.99	4.97	0.99	1.99	0.99	0.00	1.99	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	152.55	33.37	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	255.57	11.27	4.15	4.15	0.00	0.00	1.19	0.00	2.96	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	254.66	15.84	3.66	1.22	1.22	3.66	0.00	0.00	3.66	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	269.19	26.60	3.80	2.53	1.27	2.53	1.90	0.00	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	113.82	7.24	4.83	1.72	0.00	1.03	0.00	0.00	2.41	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	103.16	12.90	4.30	2.15	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	111.77	11.98	0.00	0.00	0.00	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	86.10	20.66	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	68.05	13.45	4.48	0.81	0.00	0.41	0.41	0.00	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	62.76	13.51	0.79	0.79	0.00	1.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	51.88	11.79	1.18	2.36	0.00	0.59	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	47.07	13.71	2.81	0.62	0.62	0.31	0.00	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	22.72	2.67	1.34	1.34	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	10.64	0.00	3.55	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	43.66	25.68	2.57	0.00	2.57	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	55.76	15.83	0.00	0.00	0.69	0.69	0.00	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.24	15.34	0.49	0.00	0.00	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	30.28	8.97	1.12	0.00	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	25.44	9.54	1.27	0.00	0.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.94	11.28	0.00	0.40	0.00	0.00	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	15.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	16.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	17.60	9.71	0.00	0.00	0.00	1.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	31.63	0.00	0.00	4.52	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	84.73	9.33	1.98	0.60	0.60	0.40	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	74.63	8.44	1.62	0.65	0.00	0.32	0.00	0.00	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	81.49	11.20	2.04	0.00	1.02	1.02	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	420.13	9.28	7.74	0.77	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	891.10	27.40	17.72	1.89	3.78	2.83	4.72	3.78	1.65	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	727.69	258.78	4.17	4.87	3.01	3.01	0.00	0.00	2.32	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	4.27	8.55	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	133.16	8.63	0.92	0.31	0.92	0.21	0.10	0.00	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	213.79	26.33	4.54	2.27	2.72	1.59	0.45	0.23	0.45	2.04
mesothelioma cell line:Mero-41	10851-111F5	607.03	46.45	9.05	3.67	3.18	1.96	0.24	0.24	2.44	1.96
mesothelioma cell line:Mero-48a	10852-111F6	430.24	20.81	12.40	3.54	3.10	2.44	0.66	0.66	0.66	2.21
mesothelioma cell line:Mero-82	10853-111F7	278.57	25.49	5.52	2.63	2.89	2.37	0.79	0.26	1.31	3.42
mesothelioma cell line:Mero-83	10854-111F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	197.16	39.94	2.27	0.76	1.77	1.26	0.00	0.00	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	86.34	40.99	9.52	0.62	2.28	1.04	0.83	0.41	0.62	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	616.04	43.07	9.28	6.29	5.96	2.98	1.33	0.66	2.82	2.15
mesothelioma cell line:NCI-H226	10846-111E9	287.96	70.95	2.53	2.53	3.26	1.27	0.00	0.00	1.63	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	197.64	23.23	7.00	2.22	1.88	1.20	0.17	0.00	0.68	0.68
mesothelioma cell line:NCI-H28	10845-111E8	55.98	30.28	0.00	0.25	0.25	0.51	0.00	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	166.04	26.75	1.30	2.28	0.33	0.65	0.98	1.30	0.98	0.98
mesothelioma cell line:ONE58	10858-111G3	316.47	19.78	3.25	0.81	2.71	3.25	0.00	0.00	2.44	0.81
migratory langerhans cells, donor1	11901-125F2	379.24	23.99	6.91	1.34	0.96	0.38	1.15	0.19	1.92	1.15
migratory langerhans cells, donor2	11902-125F3	292.10	17.71	6.47	0.98	0.37	0.85	0.12	0.12	1.10	0.37
migratory langerhans cells, donor3	11903-125F4	189.35	40.56	9.33	1.62	0.54	0.54	0.18	0.18	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	62.03	11.10	1.31	0.98	0.65	1.63	0.00	0.00	2.61	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	66.34	10.38	2.12	1.27	0.64	0.85	2.12	1.70	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.04	12.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.60	6.66	0.95	0.00	0.00	0.00	0.00	0.00	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.21	108.84	0.00	0.74	1.29	1.11	0.00	0.00	0.74	0.18
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	368.80	23.34	17.25	0.00	0.51	0.00	1.52	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	162.99	15.30	6.86	0.39	0.59	1.18	0.00	0.00	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	73.54	0.78	0.33	0.11	0.11	0.56	0.00	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	73.98	0.74	0.00	0.07	0.00	0.22	0.00	0.00	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	211.96	4.97	2.76	0.00	0.00	1.10	0.00	0.00	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	9.20	14.03	5.75	0.00	0.00	0.23	2.30	3.45	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	98.03	31.99	6.36	0.19	0.37	0.75	2.62	1.31	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	17.29	17.71	7.80	0.21	0.21	0.63	0.42	1.90	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	65.22	68.76	4.85	0.56	0.93	0.37	8.01	7.27	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	59.78	2.37	22.77	0.24	0.71	0.71	8.07	14.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	197.34	10.14	23.76	2.69	2.38	2.69	9.82	9.19	1.27	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	35.82	10.06	2.01	0.60	0.20	0.20	0.00	0.20	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	47.05	10.81	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	664.09	33.27	9.05	2.93	2.93	2.13	1.06	0.53	1.86	1.33
neutrophil PMN, donor1	12133-128D9	357.00	89.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	810.12	53.12	0.00	0.00	0.00	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	814.47	85.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	48.37	245.06	0.17	0.85	0.85	0.85	0.00	0.17	1.35	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	36.82	19.21	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	475.46	31.42	9.94	2.56	4.49	6.09	0.96	0.32	3.53	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	325.30	31.01	4.73	4.20	2.63	3.15	0.00	0.53	3.94	2.10
nucleus accumbens, adult, pool1	10037-101F1	94.40	8.16	62.15	0.56	0.37	0.09	17.25	20.72	0.19	0.37
occipital cortex - adult, donor10196	10172-103C1	55.63	8.24	92.72	4.12	0.00	0.00	18.54	39.15	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	72.73	11.81	39.72	0.27	0.00	1.34	5.10	2.68	1.61	0.27
occipital cortex, newborn, donor10223	10355-105E4	57.50	12.74	33.12	0.36	0.00	0.36	17.11	15.29	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	78.19	11.02	75.83	7.08	0.52	4.46	17.58	17.32	1.31	1.05
occipital lobe, fetal, donor1	10073-102A1	65.65	11.59	38.19	2.15	0.00	0.43	21.03	28.75	3.43	0.00
occipital pole, adult, pool1	10036-101E9	56.69	4.02	79.47	0.24	0.47	0.24	12.61	18.13	0.16	0.55
olfactory region, adult	10195-103E6	62.67	2.87	51.01	1.15	0.57	1.15	11.08	10.70	0.38	0.38
optic nerve, donor1	10277-104E7	106.06	10.01	58.03	2.00	0.00	0.00	6.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	160.04	87.14	5.70	1.03	1.25	2.62	0.23	0.23	0.80	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	22.53	0.55	0.14	0.00	0.00	0.14	0.00	0.00	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.00	1.86	0.51	0.34	0.17	0.17	0.00	0.00	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	245.11	8.89	5.66	1.50	1.85	1.50	0.23	0.12	0.92	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	325.42	22.64	9.70	0.88	1.18	3.23	0.29	0.29	1.18	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	327.02	9.34	17.75	0.00	0.93	0.93	5.61	6.54	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	231.78	32.02	1.91	1.91	0.64	1.06	0.00	0.00	0.42	0.42
ovary, adult, pool1	10020-101D2	515.99	24.02	15.72	2.10	1.66	3.32	5.68	3.49	1.57	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	138.41	32.45	8.98	0.55	1.10	0.73	0.55	1.10	1.47	0.18
pancreas, adult, donor1	10049-101G4	85.60	43.27	5.64	2.82	0.94	0.00	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	112.09	13.70	0.00	0.28	0.00	1.12	0.00	0.00	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	106.81	15.50	7.50	1.36	0.68	1.02	0.68	0.17	1.70	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1136.23	19.37	9.60	2.65	3.15	3.64	1.32	0.00	2.15	4.14
paracentral gyrus, adult, pool1	10035-101E8	73.22	5.31	85.66	0.27	0.55	0.18	11.44	15.38	0.27	0.09
parietal cortex, adult, donor10258	10373-105G4	45.51	5.14	47.71	0.73	0.73	1.47	7.34	9.54	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	57.37	1.88	47.96	0.94	0.94	1.88	11.29	5.64	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	65.27	10.83	47.03	0.57	0.29	0.57	3.71	9.98	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	85.56	5.99	81.16	0.62	0.53	0.09	12.34	14.89	0.53	0.35
parietal lobe, fetal, donor1	10072-101I9	37.82	7.76	31.03	1.94	0.00	0.97	24.25	26.19	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	124.12	34.02	27.67	0.37	1.12	0.75	13.09	14.21	0.37	0.75
parotid gland, adult	10199-103F1	149.85	27.13	0.62	0.62	0.00	0.62	1.23	0.62	1.23	0.00
penis, adult	10200-103F2	508.11	17.19	18.26	3.76	3.22	3.76	2.15	0.54	3.22	5.37
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	35.70	5.02	8.92	0.19	0.56	0.37	1.86	2.23	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	49.68	8.45	0.87	0.29	0.44	0.29	0.00	0.15	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	30.96	7.74	3.23	0.00	0.65	0.00	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	36.12	10.66	4.15	0.00	0.00	1.78	0.59	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	31.35	5.02	5.64	0.63	0.63	0.00	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	86.00	43.51	25.30	1.01	2.02	1.01	5.06	4.05	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	65.67	29.19	32.31	1.56	0.52	0.00	3.13	4.17	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	58.74	29.79	19.58	0.85	0.85	0.85	5.96	5.11	0.85	0.00
placenta, adult, pool1	10021-101D3	472.26	10.97	7.10	1.29	1.51	2.47	0.32	0.54	0.97	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	59.19	28.07	1.32	0.79	0.53	0.66	0.00	0.13	0.93	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	137.12	27.24	0.00	0.47	0.93	0.31	0.00	0.00	0.16	0.31
pons, adult, pool1	10033-101E6	67.56	7.14	68.08	0.17	0.43	0.43	16.27	13.25	0.26	0.26
postcentral gyrus, adult, pool1	10032-101E5	59.54	3.75	73.49	0.52	0.78	0.35	13.34	18.05	0.52	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	81.56	131.76	2.09	0.00	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	170.75	126.68	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	187.77	140.83	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	112.45	54.77	2.48	0.87	1.17	0.73	0.29	0.00	0.58	0.58
prostate cancer cell line:PC-3	10439-106E7	299.11	105.09	5.26	0.73	1.82	1.82	0.73	0.00	0.91	1.45
prostate, adult, pool1	10022-101D4	457.54	17.23	12.15	1.45	2.36	2.00	1.63	0.73	1.09	1.27
putamen, adult, donor10196	10176-103C5	27.15	5.67	25.02	0.47	0.00	0.24	17.23	25.73	0.71	0.24
putamen, adult, donor10252	10152-102I8	19.61	1.96	7.84	0.00	0.00	0.00	3.92	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	95.07	29.51	14.21	2.19	1.09	1.09	7.65	12.02	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.64	2.42	31.65	0.48	0.24	0.24	9.66	17.88	0.72	0.24
putamen, newborn, donor10223	10365-105F5	124.44	29.99	23.24	1.50	0.00	2.25	9.75	9.00	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	210.93	12.51	0.29	0.87	0.00	0.58	0.00	0.00	0.58	0.00
rectum, fetal, donor1	10067-101I4	776.17	40.34	37.56	9.74	1.39	2.78	16.69	22.26	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	474.45	78.65	37.95	3.39	1.70	1.27	1.70	1.27	1.48	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	268.41	31.07	2.90	1.66	2.90	2.07	0.41	0.00	1.24	0.83
retina, adult, pool1	10030-101E3	276.83	30.12	17.89	0.80	0.70	0.70	2.48	1.99	0.40	0.30
retinoblastoma cell line:Y79	10475-106I7	4.94	31.18	3.12	1.04	0.26	0.26	1.30	1.30	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	676.71	116.56	12.42	2.83	2.83	2.95	3.20	3.57	1.48	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	264.33	73.67	11.25	0.84	0.84	0.28	2.25	4.22	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	568.39	35.62	16.67	0.00	0.76	0.76	0.76	1.52	1.52	1.52
salivary acinar cells, donor1	11771-123I7	58.92	3.24	3.56	0.32	0.32	0.32	0.00	0.00	0.32	0.81
salivary acinar cells, donor2	11772-123I8	46.68	3.86	2.07	0.28	0.41	0.69	0.00	0.00	0.28	1.10
salivary acinar cells, donor3	11773-123I9	104.60	5.96	6.62	0.66	0.66	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	187.03	63.49	4.00	1.14	0.57	0.00	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	128.66	8.52	7.17	0.59	0.76	0.84	0.51	0.51	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	109.21	6.23	6.82	0.71	0.59	0.35	0.47	0.47	0.35	0.35
seminal vesicle, adult	10201-103F3	471.40	70.37	6.35	7.94	4.23	3.17	1.59	1.06	6.35	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	564.31	50.29	5.59	4.86	4.37	3.16	0.24	0.00	3.89	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	523.39	13.84	6.54	6.29	3.27	3.77	0.75	1.51	4.53	3.02
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	334.18	18.06	6.02	6.02	6.02	4.01	0.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	530.97	67.16	4.30	3.09	4.30	1.88	1.21	0.54	2.42	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	66.21	5.97	0.88	0.33	0.44	0.33	0.00	0.00	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	62.42	0.71	1.42	0.00	0.71	1.42	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	147.64	2.28	2.76	0.12	0.60	2.28	0.24	0.24	0.48	1.32
skeletal muscle, fetal, donor1	10066-101I3	1045.22	34.17	27.14	26.13	6.03	14.07	15.08	9.05	24.12	2.01
skin, adult, donor1	10074-102A2	312.12	0.00	6.79	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	480.36	37.24	25.88	16.41	0.00	6.94	3.16	1.26	10.73	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.03	60.70	4.00	0.33	0.33	0.00	0.00	0.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	215.29	96.45	15.13	3.15	2.52	3.78	8.51	4.73	2.84	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	39.71	71.70	16.96	0.77	1.73	2.51	4.24	11.95	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.20	15.12	0.00	0.00	0.00	0.16	0.16	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	93.49	45.33	8.50	0.65	0.22	0.44	0.00	0.00	0.65	0.22
small intestine, adult, pool1	10024-101D6	261.94	21.98	8.60	1.43	0.84	3.94	0.48	0.84	0.84	2.03
small intestine, fetal, donor1	10064-101I1	241.77	24.57	12.04	3.19	1.72	1.72	9.09	3.93	3.93	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	347.23	39.49	13.34	7.69	1.03	3.08	0.00	0.00	5.13	0.51
smooth muscle, adult, pool1	10048-101G3	721.09	11.63	17.32	4.91	3.10	4.65	0.26	0.00	3.62	1.03
somatostatinoma cell line:QGP-1	10781-110G7	86.30	77.19	8.04	0.54	0.27	0.00	0.00	0.00	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	80.75	8.95	26.15	0.69	0.92	1.38	3.90	2.98	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	85.56	18.53	14.59	0.39	0.39	0.79	1.18	1.18	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	86.47	10.38	29.06	0.00	0.00	0.00	4.84	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	186.00	26.83	39.64	2.44	0.61	0.61	20.12	16.47	4.27	0.00
spinal cord, newborn, donor10223	10359-105E8	104.24	23.42	16.53	1.38	0.92	0.46	1.38	2.30	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	821.30	30.17	8.36	1.94	4.48	2.39	0.90	0.90	2.09	0.75
spleen, adult, pool1	10025-101D7	210.25	35.90	5.51	0.88	1.10	1.76	0.11	0.44	1.10	1.21
spleen, fetal, pool1	10044-101F8	281.43	51.09	10.09	1.03	0.32	0.72	1.11	0.87	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	191.96	15.19	1.14	1.14	0.95	1.14	0.57	0.57	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	268.73	35.29	5.59	2.45	2.80	1.40	0.00	0.00	2.45	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	256.45	4.30	1.56	0.78	1.17	1.17	1.95	0.39	0.78	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	64.27	0.56	2.03	0.45	0.56	0.56	0.00	0.11	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	82.18	61.00	6.35	1.69	0.85	0.85	0.85	0.00	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	432.38	24.54	6.35	0.00	0.85	0.00	0.00	0.00	1.27	0.42
stomach, fetal, donor1	10062-101H8	607.68	67.28	18.16	4.27	0.00	1.07	3.20	6.41	2.14	6.41
submaxillary gland, adult	10202-103F4	139.57	31.33	0.57	3.99	0.57	1.14	1.14	1.14	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	54.27	54.27	0.00	108.55	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	95.13	16.62	12.67	0.83	0.42	0.21	0.62	0.21	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	45.00	10.86	39.83	0.00	0.00	0.00	10.86	8.28	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	117.29	15.54	16.96	0.71	0.00	2.12	10.60	3.53	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	294.84	80.93	35.99	1.15	2.06	1.15	10.09	12.38	2.29	0.69
temporal lobe, adult, pool1	10031-101E4	80.79	5.26	78.41	0.17	0.51	0.34	13.90	21.19	0.17	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	57.69	10.68	25.64	3.56	0.71	0.00	16.38	28.49	5.70	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	48.35	9.67	19.34	3.08	0.44	0.44	14.50	24.61	3.52	0.00
tenocyte, donor1	11763-123H8	279.63	26.53	14.31	4.19	3.49	3.14	0.70	0.00	2.44	0.35
tenocyte, donor2	11765-123I1	203.72	11.06	9.16	1.53	0.76	0.00	0.00	0.38	0.76	1.14
tenocyte, donor3	11768-123I4	256.13	22.61	4.82	1.48	0.74	0.37	0.00	0.00	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	122.03	41.64	3.57	0.51	1.36	1.02	1.87	2.89	1.36	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	212.11	16.03	11.41	2.93	2.16	1.54	8.17	8.02	0.77	1.23
teratocarcinoma cell line:PA-1	10807-111A6	96.40	31.77	8.52	0.62	0.62	0.93	4.96	11.31	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	307.97	40.37	3.17	2.16	1.02	3.30	0.51	0.51	0.89	2.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	333.55	52.94	6.43	1.13	1.51	1.51	1.51	0.76	1.13	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	337.77	6.33	2.29	1.96	0.87	1.64	0.76	0.22	1.74	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	333.85	16.61	8.79	2.93	2.28	5.21	6.19	4.56	3.91	1.95
testis, adult, pool1	10026-101D8	382.14	147.74	8.38	6.12	3.76	8.48	1.72	1.50	2.04	2.47
testis, adult, pool2	10096-102C6	167.80	271.55	4.06	4.06	2.26	1.35	2.71	1.80	4.96	0.90
thalamus - adult, donor10196	10168-103B6	103.77	3.31	22.08	2.21	1.10	0.00	1.10	3.31	1.10	0.00
thalamus, adult, donor10252	10154-103A1	113.77	14.85	20.79	0.94	0.94	1.41	0.94	1.41	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	127.79	9.24	36.95	0.00	1.54	1.54	9.24	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.88	3.46	20.09	0.99	0.16	0.82	2.64	1.65	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	292.84	11.51	24.16	2.30	1.73	0.00	9.78	6.90	0.58	0.00
throat, adult	10209-103G2	273.14	17.98	5.24	8.49	1.75	2.00	0.25	0.50	4.49	0.75
throat, fetal, donor1	10061-101H7	294.65	35.65	21.94	6.70	2.44	1.22	8.53	2.13	5.48	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	1.79	19.87	0.20	0.20	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	160.75	33.40	37.08	1.59	0.80	2.58	4.27	13.32	0.80	1.79
thymus, fetal, pool1	10043-101F7	236.18	33.15	31.28	1.35	1.77	0.94	4.68	9.25	0.94	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	297.83	8.24	9.97	1.99	0.93	1.73	0.66	0.40	0.80	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	207.86	31.15	5.03	1.40	1.12	1.40	1.12	0.56	1.12	1.12
thyroid, adult, pool1	10028-101E1	125.97	44.42	3.08	0.37	0.28	1.03	0.00	0.19	0.37	0.56
thyroid, fetal, donor1	10060-101H6	336.70	52.47	10.81	2.11	1.85	3.43	2.11	0.53	2.11	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	163.22	9.24	9.24	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	307.47	14.88	6.51	3.49	2.56	3.02	0.23	0.00	5.12	3.02
tongue, fetal, donor1	10059-101H5	434.29	16.95	16.16	4.73	1.58	5.12	3.55	1.58	7.88	3.15
tonsil, adult, pool1	10047-101G2	181.12	30.15	7.61	0.30	0.30	0.20	0.60	0.40	0.30	0.30
trachea, adult, pool1	10029-101E2	244.09	44.25	5.32	0.82	0.98	1.31	0.25	0.16	0.33	0.90
trachea, fetal, donor1	10058-101H4	362.77	29.24	23.08	3.46	1.54	2.69	3.46	2.69	2.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	531.41	25.15	5.31	3.54	3.19	4.61	0.00	0.00	1.42	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	166.06	36.68	1.22	0.30	0.81	0.71	0.00	0.10	0.61	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	0.31	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	319.62	13.32	17.12	0.00	0.00	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	222.72	9.57	1.78	1.10	0.76	1.52	0.42	0.25	0.51	1.10
umbilical cord, fetal, donor1	10057-101H3	527.88	8.35	20.87	2.09	2.09	8.35	4.17	6.26	0.00	4.17
uterus, adult, pool1	10100-102D1	1314.86	30.03	46.92	3.92	1.19	2.22	6.48	6.48	2.90	4.10
uterus, fetal, donor1	10055-101H1	688.03	43.51	31.74	6.66	2.05	0.51	12.80	16.89	5.63	2.56
vagina, adult	10204-103F6	255.25	5.82	1.94	0.00	0.65	1.94	0.00	0.00	0.00	1.94
vein, adult	10191-103E2	335.81	21.48	10.30	4.60	2.41	3.95	0.88	0.66	4.60	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00